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ABSTRACT 
 
Perfusion in biological system refers to capillary-level blood flow in tissues, and 
is a critical parameter used for detecting physiological changes. Medical imaging 
provides an effective way to measure tissue perfusion. Quantitative analysis of perfusion 
studies requires the accurate determination of the arterial input function (AIF), which 
describes the delivery of intravascular tracers to tissues. Automating the process of 
finding the AIF can save operating time, remove the inter-operator variability, and 
correct the errors in the presence of the dispersion of the arterial system. Even though 
several methods are currently developed for automatically extracting an AIF, they are 
specific to a single modality and particular to a certain tissue. 
 
In this thesis, we developed an algorithm to automatically determine an AIF by 
classifying the characteristic parameters of image pixels' dynamic evaluation curves 
between blood feeding areas and tissues. This automated AIF determination can be used 
to facilitate the generation of parametric maps for perfusion studies based on various 
imaging modalities and covering a variety of tissues. Automatic AIF determination was 
accomplished by extracting characteristic parameters such as maximum slope, maximum 
enhancement, time to peak, time to wash-out, and wash-out slope. Multi-dimensional 
data containing the characteristic parameters were converted and reduced into two-
dimensional (2-D) representations, which were presented as a plurality of 2-D plots. 
Then physiological phases were localized within the simplified representations. 
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Automated segmentation of non-AIF tissues and determination of AIF areas were 
accomplished by automatically finding peaks and valleys of each physiological phase on 
the plurality of 2-D plots. The algorithm was tested in CT myocardial perfusion studies, 
in which a pig was used as a model of myocardial ischemia and perfusion. PET 
gastrointestinal (GI) perfusion studies were performed using this algorithm, in which GI 
perfusion was evaluated when cardiac outputs were controlled with four modes. This 
automated AIF determination study was compared with manual selection of AIF in PET 
imaging and microsphere studies to assess the effectiveness of this algorithm. In the CT 
myocardial perfusion study, the perfusion of infarcted myocardium was significantly 
lower than that of non-infarcted areas and lower than that when it was normal. In the 
PET abdominal perfusion study, PET imaging data gives lower value of standard 
deviation relative to the mean than that in microsphere results. In the manual AIF 
selection study, a slight change in selecting the AIF region caused a big influence on the 
result. On the contrary, the automated AIF selection remains consistent in the entire 
study and reduces inter-operator variation.  
 
A conclusion was made that this technique is applicable to several imaging 
modalities, such as PET, CT and MRI, and is effective on many tissues. In addition, this 
algorithm is straightforward and provides consistent results. More importantly, this 
automated AIF determination technique replaces the conventional spatial classification 
method with the functional classification method, taking more physiological 
considerations and explanations involved.  
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Perfusion 
Perfusion describes the amount of blood that passes through the capillary beds of 
a volume of tissue per unit time; whereas the blood pool traveling straight through the 
blood feeding areas, such as arteries and veins, should not be considered as perfusion (1). 
Figure 1 demonstrates a perfusion process in a general tissue. In the perfusion process, 
the blood is assumed to be neither metabolized nor absorbed by the tissue through which 
it traverses. Tissue perfusion is a measure of the capability of the central cardiovascular 
mechanisms to deliver oxygen to the peripheral tissue for meeting metabolic needs (2). 
Since it is closely related to oxygen and nutrient transfer, it becomes an essential 
parameter used for diagnosis of physiological changes in some cases, such as ischemic 
stroke, tumor, cardiac infarction and inflammation.  
 
Figure 1. Perfusion process should only be considered at the capillary beds in 
tissues. 
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1.2 Tracer Kinetics 
In perfusion studies, tracers are always used to label blood so that the information 
about the blood flow can be detected and monitored. The biodistribution and kinetics of 
the tracer are key components to study tissue perfusion. Based on different physical and 
biological properties of tracers, their kinetics are modeled in different ways to define the 
relationship between the measured data and physiological parameters, represented by the 
uptake and metabolism of tracers. The quantitative and semi quantitative assessment of 
tissue perfusion requires the application of tracer kinetic modeling techniques. The tracer 
kinetic models in quantitative assessment are used for building a mathematical 
framework for calculating the concentration of input and output to help understand the 
rate of biological processes. In perfusion studies, the tracer kinetic model is used to 
estimate biological parameters through fitting a mathematical model to the dynamic 
evaluation curve of a pixel or a region of interest (ROI) based on the change of pixel 
intensities over the dynamic time evaluation. Generally, the tracer kinetic modeling 
technique is divided into model-driven and data-driven methods (3). The difference 
between the two is that the model-driven method is based on a particular compartmental 
structure to estimate and describe the behavior of the tracer and further the parameters of 
the biological system (4). On the other hand, the data-driven method is mostly based on 
graphical analysis—Patlak plot (5, 6) and Logan plot (7, 8)—and derives the parameters 
from a graphic description of the kinetic processes. However, both the model-driven and 
data-driven methods are based on the knowledge of compartment structures (Figure 2). 
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Figure 2. Compartmental models with first-order transfer rate constants (K1, k2, k3 
and k4) describing the flux of tracer between compartments. Cp denotes the 
concentration of tracer in arterial plasma, CF+NS the concentration of free and 
nonspecifically bound tracer in the target tissue, CSP the concentration of 
specifically bound tracer in the target tissue. 
 
In order to interpret the tracer behaviors inside the body, we assume that the 
subjects who interact with tracers are physiologically separated into several pools of 
tracer substance, termed as "compartments". The common models are one 
irreversible/reversible compartment and two irreversible/reversible compartments 
(Figure 2). Compartmental models with first-order transfer rate constants (K1, k2, k3, k4) 
describe the flux of tracers between compartments. The tracers are infused into the 
arterial blood (plasma), and then pass into the first compartment. If the tracers are 
completely trapped by this compartment, we say that it is a one-compartment model. The 
categories of irreversible models and reversible models are dependent on whether the 
tracers inside the first compartment exchange with the plasma or not. If the first 
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compartment is a nonspecific-binding compartment that exchanges with the plasma, and 
then there is another compartment called specific binding region, we call this model as 
two-compartment model. The categories of irreversible and reversible models are 
determined by the exchanging status of the second compartment.  
 
1.3 Perfusion "Gold Standard" Study—Microsphere Study 
The most widely used techniques to measure regional tissue perfusions are 
deposition techniques. The basic principle of these kinds of techniques is that the 
deposition of tracers injected is proportional to the blood flow in per unit volume/mass 
of tissues. In other words, the amount of the cardiac output travelling to a certain region 
is determined by the deposition of a tracer within that region (9). The ideal deposited 
tracers are able to provide a measure of blood flow at the level of the capillaries within a 
certain volume of the tissue. In addition, the tracers are not metabolized by the organ 
since the blood fraction of a tissue is not equal to the metabolism fraction of the organ.  
 
The current "Gold Standard" technique to measure blood flow is to employ non-
diffusible labeled tracers—microspheres. Microspheres are small spherical or irregularly 
shaped particles that are larger than capillaries (usually with the diameter larger than 12 
micons (9)). After the microspheres are injected through the left atrium or ventricle, they 
embolize the first capillary bed they encounter and remain within the capillary beds for a 
sufficiently long time until the particles break down and are excreted out of the body. 
Since microspheres are injected into the left atrium or ventricle, they are delivered to 
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individual organs with the proportion to the blood flow to the organ. The requirement of 
injection of the microspheres into the left atrium or ventricle is to avoid extraction of 
particles by the lungs.  
 
However, one of the disadvantages of microsphere measurement is that the 
process is usually invasive, because tissue biopsies are harvested for the microsphere 
analysis. In addition, this technology might lead to microembolizaton of the capillaries 
due to blood flow blocked by the accumulation of the particles. Therefore, only a small 
amount of microspheres can be injected. Lastly, microsphere measure is very subject to 
the technique itself, which means that slight changes can have a large effect on the 
sample if operators are not careful. 
 
1.4 Medical Imaging Modalities for Perfusion Study 
1.4.1 Single Photon Emission Computed Tomography (SPECT) Imaging 
Nuclear medicine techniques use pharmaceuticals labeled with radionuclides, 
called radiopharmaceuticals, as tracers for the diagnosis and treatment of disease. 
Essentially, gamma radiation, which is non-particulate and penetrating, is emitted from 
the body through radiopharmaceuticals decay and measured by external radiation 
detectors. The radioactive tracer, combined with physiological process, can functionally 
assess the tissue activity, rather than anatomic or structural detail (10). The two 
commonly used nuclear medicine techniques in perfusion studies are single photon 
emission computed tomography (SPECT) and positron emission tomography (PET).  
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In SPECT, the collimated gamma camera moves in a circular or elliptical orbit 
around the patient and acquires projection images at multiple angles. Since the 1980s, 
SPECT has become the clinical gold standard in tissue perfusion studies. By measuring 
the uptake and distribution of the radionuclide tracer—usually either technetium or 
thallium—in the tissue in different states or stages, SPECT allows a three-dimensional 
assessment of the tissue perfusion and viability (11). SPECT tracers are designed so their 
distribution is nearly proportional to tissue perfusion, with the ideal condition of a 
relatively high first-pass extraction fraction and retention in the tissue through high 
chemical affinity (12). The technique has a relatively high accuracy in diagnosis. In 
myocardial perfusion studies, for example, the specificity is around 87-94% and the 
sensitivity 85-90% (11, 13, 14). However, SPECT requires a tracer dependent radiation 
dose that is normally really high and a long examination time. Furthermore, variable soft 
tissue attenuation leads to apparent defects, shown as lack of perfusion, interfering with 
quantitative analysis and diagnosis (10). The limitations in spatial and temporal 
resolution of SPECT might also hamper the assessment of the slight difference of 
perfusion, resulting in some mistakes in diagnosis. In clinical use, the cost for this 
technique is moderately high, approximately $1,000. 
 
1.4.2 Positron Emission Tomography (PET) Imaging 
1.4.2.1 PET Physics 
Similar to SPECT, PET is a tomographic technique that is used for measuring 
physiology, as well as function, instead of anatomy and structure. Principally, a 
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radioactive tracer labeled with a positron emitting isotope is introduced into the body, 
usually through intravenous injection. It is then distributed in tissues in a manner of 
physiological properties of the different tissues. The isotope decays by emitting a 
positively charged electron—positron—which undergoes annihilation with an electron 
within the body, followed by a pair of gamma photons of 511 KeV energy emitted in 
almost opposite directions. The high-energy photons have a good probability to escape 
from the body. The pair of gamma photons is simultaneously detected by two series of 
detectors axially surrounding the patient. The detectors convert the photons into 
electronic signals for the later on electronics transference. Approximately 10
6
 to 10
9
 
decays (events) are required per frame to achieve a necessarily statistical signal to noise, 
as stated in mCT (PET-CT) performance published by Jakoby (15). More counts usually 
give better signal-to-noise ratio (SNR), but not absolutely. According to Jakoby, for a 70 
cm long NEMA (National Electrical Manufacturers Association) scatter phantom, the 
optimal SNR can be achieved with the count rate to be 800,000 trues/sec. However, after 
the optimal count rate, the SNR slightly drops down. Noise is dominated by the counting 
statistics of the coincidence events detected. Therefore, more events detected means 
better counting statistics of estimated true value. The poor counting statistics can be 
compensated by longer acquisition time in individual frame. These events are corrected 
by several factors, such as dose calibration factor, scatter fraction factor and decay factor, 
and then are reconstructed into a tomographic image. The resulting signal intensity in a 
voxel/pixel of the image is proportional to the amount of the radionuclide in the 
corresponding pixel. Since unlike SPECT, PET can be accurately corrected for 
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attenuation, a true quantified distribution can be computed. Accordingly, using PET 
imaging data, the spatial distribution of tracers can be mapped so that quantitative 
analysis is able to be performed (16). 
 
1.4.2.2 PET Perfusion Studies 
In perfusion studies, 15-Oxygen-water can be considered the most ideal tracer 
due to its property of being non-metabolized by the tissue.   However, the use of 15-
Oxygen-water remains limited in the clinical application since it requires an on-site 
cyclotron to generate. Other common tracers, such as  82-Rubidium and  13-N-
Ammonia permit dynamic and static acquisition with a short scan time, as well as low 
radiation exposure (17). The advantages of  13-N-Ammonia and  82-Rubidium are their 
relatively high first-pass tissue extraction—65-70% for  13-N-Ammonia (18) and 60-65% 
for  82-Rubidium (19). For tracers used for perfusion studies, the higher first-pass tissue 
extraction, the better tracer distribution around the tissue we can estimate. Another 
benefit for using 13-N-Ammonia as a tracer is its long life times—9.96 min, which 
allows longer image acquisition time and better count statistics. However, like 15-
Oxygen-water, 13-N-Ammonia requires on-site cyclotron to generate.  82-Rubidium can 
be obtained by a generator, while its short life time—76 second—limits its use in the 
perfusion studies, which are high tracer concentrated studies.  
 
In perfusion studies, imaging begins with the infusion of radioactive tracers. The 
scan continues for anywhere from seven to forty minutes, with multiframe or dynamic 
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image sequence. The entire scan time depends on the properties of the tracer. Usually for 
the tissue-trapped tracers, the scan should not stop until the tracer is cleared from the 
artery-system and trapped completely by the tissue.  
 
The kinetics of the tracer when the PET imaging is performed represents the first 
pass of it travelling through the tissues. Since the signal intensities  represent the amount 
of the tracers in the corresponding pixels,  the changes in pixel intensities reflect the 
blood flow and distribution in that area. The radioactivity changing around a tissue over 
time generates the tracer enhancement curves for the tissue. 
 
One of the PET perfusion's unique properties is to measure the tracer 
concentration in regional tissue in absolute units, allowing for the homogenous spatial 
resolution throughout the field of view. Practically, the spatial resolution of modern PET 
system is approximately 0.54 mm to 10.5mm (20), which is tracer and  system 
dependent. Resolution in positron imaging is limited by mean free path of the positron. 
The more emission energy of the isotope has, the longer path the emitted positron takes 
to annihilate with an electron. The location of the annihilation spot is measured to 
estimate the actual location of the positron or the isotope. Therefore, the longer mean 
free path, the more blurred image. In addition, the resolution is also limited by 
colinearity/deviation angle. The more energy the isotope has means the bigger 
momentum it takes. The two gamma photons emitted then carry the momentum in the 
original direction. Accordingly, if the energy is too large, the colinearity is bad, and the 
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resolution is low. The high contrast resolution allows a sensitive and accurate detection 
of a slight change in perfusion with an average sensitivity of 90% and specificity of 89% 
in myocardial perfusion, for example (21). Compared to SPECT, PET has higher 
temporal resolution, which contributes to the ability of the measurement of rapid 
changes in radioactive tracer concentration in tissues. The cost of PET is relatively high, 
around $1, 850, but this method is able to provide better and more reliable results with a 
reduced radiation dose than SPECT does. 
 
1.4.3 Magnetic Resonance Imaging (MRI) 
1.4.3.1 MRI Physics 
The MRI signal derives from protons in the body, mostly existing in water, but 
also in the lipid. The proton, a polarized spin with angular momentum, behaves as a 
small magnet when the patient inside a static magnetic field. The spin precesses around 
the direction of the static magnetic field. The application of a radiofrequency (RF) pulse, 
a circularly polarized wave that contains a rotating magnetic field, interferes with the 
spins' equilibrium and excites the protons. The relaxation after the excitation can be 
encoded with rapidly changed magnetic fields and magnetic field fluctuations caused by 
molecular motion, and can produce signals that present spatially localized information 
(22, 23).  
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1.4.3.2 MRI Perfusion Studies 
The method commonly used in MRI perfusion studies is dynamic susceptibility 
contrast MRI (DSC-MRI), or dynamic contrast enhanced MRI (DCE-MRI). DSC-MRI 
is based on the technology of bolus tracking. Essentially, gadolinium is a paramagnetic 
substrate that serves as contrast agent, because it profoundly affects the signal (up to 
50%) on a gradient echo scan (24) and remains inside intravascular structures inside the 
tissue. As the contrast agent passes through the blood vessels, a big change in the 
magnetic field is produced by the gadolinium-doped blood, and the different magnetic 
fields cause the MRI signal to dephase, resulting in a progressive signal loss 
(characterized by T2*, gradient-echo echoplanar imaging (GE-EPI)). Recently, 
researchers have started to use T2-weighted spin-echo scan (spin-echo echoplanar 
imaging (SE-EPI)), as well, to study the tissue perfusion. In this scan, the signal loss 
mostly arises from the passage or the diffusion of gadolinium—causing static field 
inhomogeneity effects—through the capillaries instead of through the larger blood 
vessels.  
 
The pixel intensities from the MRI present signal intensities themselves. The 
abnormal part of the tissue will show less signal loss compared to the surrounding 
tissues. The kinetic model used for DSC-MRI in perfusion studies is, similar to PET 
perfusion studies, also based on the principle of tracer kinetic modeling techniques. The 
perfusion tracer is neither metabolized nor absorbed by the tissue through which it 
traverses. In addition, in order to make the later calculation work, the tracer should be 
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non-diffusible, so that it could be accumulated inside tissue.  In order to simplify the 
computation, one compartment irreversible model is used: the contrast flows from the 
artery (input) into the capillary bed of the tissues, accumulates inside the tissue, and 
flows out through the vein (output) without flowing back.  
 
MRI perfusion studies show high spatial and temporal resolution and no radiation 
exposure, which makes MRI a safe and clinically-used modality to assess both anatomy 
and functionality of tissues. More importantly, MRI allows semi-quantitatively 
measurements of the tissue perfusion. The foundation of calculation and analysis of the 
MRI perfusion is on the time-intensity curves. Another advantage of the MRI perfusion 
study is that it gives a high sensitivity and specificity. For example, in cardiac stress 
perfusion tests, the sensitivity and specificity are of 89% and 87%, respectively (11). 
However, the disadvantages of MRI perfusion difficult in a clinical setting are 
moderately long acquisition time (30 – 45 min), heartbeat sensitivity, and restriction in 
patients with metal implants. 
 
1.4.3 Computed Tomography (CT) Imaging 
1.4.3.1 CT Physics 
The first CT scanner was developed in 1972 by Godfrey Hounsfield, and now 
this modality has become an essential radiological technique applied in a wide range of 
clinical cases. X-rays are used in CT to generate cross-sectional, two-dimensional 
images of the body. An X-ray tube rapidly rotates by 360° around the body, and the 
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transmitted radiation is then detected by an array of sensitive radiation detectors located 
on the gantry around the patient (Figure 3). 
 
Figure 3. CT structure. 
 
Images are generated through reconstruction, an inverse problems mathematical 
technique, from multiple X-ray projections to reproduce the internal structures of the 
body. Essentially, the patient is linearly scanned by the X-ray beam and a shadow image, 
referred to as "projection" or "attenuation profile", is produced. A further rotation of the 
X-ray tube and the detector by a small angle renders another shadow image. This 
procedure is repeated many times until the patient has been scanned for a 180 degree 
rotation. The data obtained from CT scanner is modeled with Radon Transform. The 
Radon Transform allows to create film images of objects, and the inverse problems 
(inverse Radon Transform) allows converting Radon Transform back into attenuation 
profile to reconstruct the body from the scanning data. The attenuation profiles are 
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processed by the image processor, and each attenuation profile is subjected to kernel, 
which is a mathematical high-pass filter, to correct the blurred image and produce 
overshoot and undershoot at the edges of the patient. The profiles then pass through a 
mathematical operation of convolution and are further added up to produce a sharp 
image. The creation of the images is accomplished by overcoming superimposition of 
structures and presenting slight differences in tissue contrast.  
 
The CT image does not show attenuation values directly, but does show the CT 
number—Hounsfield Units (HU), the relative electron density of tissues (25). 
          
    
  
   (1) 
Where µ is the attenuation coefficient and µ w is the attenuation coefficient of water. 
Attenuation coefficients depend on electron density of tissues.  
 
A contrast (tracer) can be applied to enhance the imaging presenting in some 
certain areas through the blood flow. The contrast is usually injected intravenously. 
There are many kinds of contrast used in CT imaging, and the most common one is an 
iodine-based contrast. The principle of contrast enhancement is based on the 
photoelectric interaction of the x-rays with the iodine atoms. A contrast (iodine)-
enhanced CT imaging has always been performed at 80 KV, instead of the conventional 
120-140 KV. The determination of the tube voltage is because it is closer to the K-edge 
of iodine, which is 33.2 KeV (26). K-edge refers to a sudden increase in the attenuation 
of photons that occurs at an energy level just above the binding energy of the K shell 
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electron of the atoms interacting with the photons. These energy levels cause an increase 
photoelectric absorption (27). A maximum iodine signal can be obtained if the mean 
beam energies straddle the K-edge of iodine (28). The selection of this kilovolt (80 KV) 
can reduce the administered radiation dose to the patient as well as increase the contrast 
signal (29).  
 
1.4.3.2 CT Perfusion Studies 
CT has evolved into a reliable imaging modality for non-invasively measuring 
tissue perfusion, given the rapid acquisition time, its ability to be nearly unaffected by 
physiological noise—like heartbeat rate. An important role of CT perfusion study is to 
anatomically and functionally assess tissue abnormality. In addition, another important 
advantage of CT perfusion is the linear relationship that the change in attenuation, which 
is expressed as HU, is directly proportional to the concentration of the contrast material 
(30). This linear relationship potentially facilitates semi-quantitative measurement of 
perfusion. 
 
The CT perfusion can be divided into qualitative study and semi-quantitative 
study. The qualitative technique utilizes the visual perception of the different attenuation 
values to distinguish hypoperfused areas from normal tissue areas. The advantage of this 
method is that it can provide both anatomical and functional assessment of perfusion in a 
single test with significantly reduced radiation dose and decreased contrast injection. 
However, the accuracy is not ideal. The signal attenuations in the organ represent the 
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relatively accurate perfusion level only if the image is acquired during the contrast 
maximal enhancement. The optimal visualization, with high qualities of both view and 
time, is difficult to acquire. Furthermore, the contrast arrival times in the ischemic or 
infarcted areas are significantly delayed compared to that of the normal areas. Another 
disadvantage is that the visualization of the contrast enhancement is largely affected by 
image artifacts arising from motion and beam hardening. A true defect should be 
consistent in all the image phases, but with only one signal test, it is hard to tell the 
persistency.  
 
The modern approach for CT perfusion is dynamic CT imaging, in which 
sequential images are obtained over a defined period of time to trace the kinetics of 
contrast bolus in the blood pool and tissues. In the dynamic CT perfusion study, imaging 
is started to be performed during the first pass of contrast bolus traversing through the 
tissue microvasculature. The areas with normal perfusion uptake higher contrast and 
present brighter images than the ischemic areas with reduced perfusion. The principle is 
similar to that of DSC-MRI, and one compartment irreversible model is used. The HU 
changing over time allows the creation of the enhancement curves for the tissue, region 
of interest or individual pixels. 
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1.5 Arterial Input Function (AIF) Determination 
1.5.1 Dynamic Evaluation Curves (DEC) 
The dynamic evaluation curves represent the tracer tracking in a certain region 
along the dynamic imaging sequence. The specific name for DEC depends on the 
particular meaning presented by pixel intensities from each imaging modality. For PET 
imaging, the dynamic evaluation curve is the time-activity curve (PET-TAC); for MRI 
imaging, it is the time-intensity curve (TIC); and for CT imaging, it is the time-
attenuation curve (CT-TAC). In all the imaging modalities, the dynamic evaluation 
curves involve the tracer kinetics of baseline, wash-in, wash-out and steady state (Figure 
4). However, the presenting of them varies with imaging modalities, imaging protocols 
and tracer properties. For example, the time-intensity curves generated from DSC-MRI 
shows negative contrast enhancement (Figure 5A), while the CT-TACs and PET-TACs 
present the positive contrast enhancement—showing peaks. For the diffusible tracers, 
the wash-out process is displayed as clearing-up. However, the non-diffusible tracers 
will be trapped into the tissue, and therefore, the wash-out process cannot show up in 
tissues (Figure 5B). 
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Figure 4. A general presenting of a dynamic evaluation curve. 
 
 
Figure 5. Two cases of dynamic evaluation curves. A. Dynamic evaluation curve for 
DSC-MRI; B. Dynamic evaluation curve for non-diffusible tracer kinetics in tissue 
and artery. 
 
The dynamic evaluation curves are utilized in generating perfusion parametric 
maps to demonstrate the blood distribution and contrast clearance rate, which are shown 
by tissue blood flow (TBF), blood volume (TBV) and mean transit time (MTT). TBF is 
defined as the volume of blood moving through a given vascular network in the tissue 
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per unit time, with units of milliliters of blood per 100g of the tissue per minute 
(ml/min/100g). TBV is described as the total volume of flowing blood within the 
vascular network, with units of milliliters of blood per 100g of the tissue (ml/100g). 
MTT is defined as the average transit time of all blood elements entering the arterial 
input and leaving at the venous output of the vascular network, measured in seconds (s) 
(31, 32). A relationship exists among these three parameters:  
              (2) 
Therefore, once two parameters are obtained, the other one can be simultaneously 
calculated. 
 
1.5.2 Perfusion Quantitative Analysis 
The quantitative analysis—TBF, TBV, and MTT—of tissue perfusion relies on 
dynamic evaluation curves by using maximum slope (upslope) model, model-based 
deconvolution mathematical modeling and trapped-tracer model, which are tracers and 
modality dependent. 
 
1.5.2.1 Maximum Slope Method 
Maximum slope analysis is also called upslope analysis, which means to 
compute perfusion maps from the maximum slope of DECs of the tissue. This method is 
usually applied in MRI and CT perfusion studies. 
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The computation process is based on four general assumptions. First, a perfusion 
tracer is neither metabolized nor absorbed by the tissue through which it traverses. 
Second, the maximum slope method is based on Fick's Principle of conservation of mass 
to a given region of interest (the tissue studied) (31). The essence of the principle is on 
the basis of one-compartment model, and is generally defined as the amount of a 
substance in a compartment at any moment in time yields to the integral over time of the 
net rate of flow of the substance into the compartment. The net rate of flow is equal to 
the difference between inflow and outflow (Figure 6A). In the perfusion study, the 
substance is the contrast agent, and the inflow is the contrast flowing inside the artery, 
while outflow is the contrast flowing inside the vein. The net flow is the contrast within 
the tissue (Figure 6B).  
 
Figure 6. The model for Fick principle of conservation of mass (A) and the 
associated one-compartment model for tissue perfusion studies. In (B), Cartery, Cvein 
and Ctissue are the contrast concentrations in the artery, vein and tissue, respectively. 
Qin and Qout are the blood flows, with contrast included. 
 
 21 
 
In this assumption, there is only a single inflow (artery), a single outflow (vein), 
no delays (instantaneous bolus injection), and no dispersion (one pathway of blood). The 
third assumption is that perfusion is an incompressive fluid dynamic process, which 
means that inflow equals to outflow, corresponding to the interested tissues 
             (3) 
Where Qin (velocity/time) and Qout are the flow-in and flow-out blood flows, with 
contrast included.  
 
According to the law of conservation of mass, it comes to  
                      ∫                            
 
 
 (4) 
Where Cartery (mass/volume), Cvein and Ctissue are the contrast concentrations in the artery, 
vein and tissue, respectively. M (t) is the accumulated mass of contrast at a moment in 
time. V is the volume of the tissue.  
 
The equation of mass conservation can be simplified as  
                         (5) 
The mass of accumulated contrast yields to the difference between the mass of wash-in 
contrast and the mass of wash-out contrast. 
 
The forth assumption is that the maximal mass accumulation of the contrast 
within the tissue occurs when the perfusion process turns into an irreversible one-
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compartment model—this means that the concentration of the contrast inside the blood 
flow of the vein yields to zero (Cvein = 0). And the equation (4) turns out to be 
                ∫             
 
 
 (6) 
 
TBF is the flow per unit tissue volume, and thus  
       ⁄   
          ⁄
       
  (7) 
 
At this time, mass accumulation is the maximum, and since the general blood 
flow, Q, will not change, the concentration of the contrast inside artery will be the 
maximum  
                         (8) 
 
At the same time, in equation (6), since the flow Q, volume V, and the 
concentration Cartery are constant, dCtissue/dt must also be constant. This means that  
 
         
   
   (9) 
 
Therefore, in this moment, the concentration of the contrast inside the tissue is in 
the status of being maximum upslope 
 
        
  
         (10) 
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In sum, based on the assumptions aforementioned, it turns out the equation that 
demonstrates that the rate of contrast accumulation will peak when the arterial 
concentration is maximal. 
 (
        
  
)                      (11) 
 
Hence, TBF can be represented as the ratio of the maximum slope of tissue DECs 
to the maximum arterial concentration. 
 
Tissues contain the vasculature, cells and the interstitium, and TBV measures 
fractional vascular volume—the volume of distribution. 
      
            
                                   
  
           
       
 (12) 
Since the perfusion process does not count contrast absorption and metabolism, 
all the contrast inside the tissue only exists in microvasculature surrounding or in the 
tissue 
                                            (13) 
 
According to the law of conservation of mass, the amount of the contrast flowing 
from the artery into the microvasculature in the tissue does not change. 
         ∫             
 
 
   ∫                   
 
 
 (14) 
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Based on the equations of (12), (13), (14), it turns out 
      
∫                  
 
 
∫             
 
 
 (15) 
 
This is an ideally simplified method to calculate TBV. However, in fact, some 
corrections need to be considered: ρ, tissue attenuation, which varies by tissues, and CH, 
a correction factor to adjust the difference between arterial and microvasculature 
hematocrit (31, 33). The more accurate calculation to get TBV is demonstrated in the 
equation (16). 
      
  
 
 
∫                  
 
 
∫             
 
 
 (16) 
 
Since the two correction numbers are not easy to obtain, researchers always use 
equation (15) to get the estimated TBV, and results are well shown. 
MTT is either measured from the first detection of contrast to the contrast wash-
out point, or calculated from equation (1) (31, 34). The calculation from equation (1) is 
more accurate since the detection of the contrast wash-in and wash-out is not easy. 
 
Compared to other methods, the maximum slope method is simple, and thus the 
speed of calculation of perfusion parameters is high. The maximum slope method yields 
relative, rather than absolute, perfusion assessment. It is both efficient and accurate. 
Another advantage is that this analysis method only requires imaging to just a portion of 
the DEC, reducing the radiation exposure. However, a high rate of contrast injection-as 
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high as 10 ml/s-is required to satisfy the assumption of no venous outflow. In clinical 
practice, it is hard to achieve this high injection rate. Therefore, it is utilized in 
preclinical studies, instead of routinely achieved in clinical practice (31). 
 
1.5.2.2 Model-Based Deconvolution 
Generally speaking, this model used for perfusion quantification is based on the 
principles of tracer kinetics for non-diffusible tracers (1). It utilizes the two-compartment 
model that besides the contrast flowing into the capillary bed of the tissue, it also 
remains in the intravascular space (35). However, the calculation still obeys the 
assumptions of Fick Principle of conservation of the mass, one inflow (artery) and one 
outflow (vein), and non-absorbable and non-metabolized. This model can be applied in 
MRI and CT perfusion studies. 
The concentration of the contrast agent inside the tissue can be defined in terms 
of three functions (1, 31, 32): 
 
1) Transport function, h (t): the probability density function of tissue transit time 
through the given volume of interest at the moment t in time, with the condition 
of an ideal instantaneous bolus injection. This function relies on the vascular 
structure and blood flow inside and presents the distribution of the transit time 
over an individual voxel.  
 
2) Residue function, R (t): the fraction of injected tracer that still remains in the 
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tissue voxel of interest at the moment t in time, following an ideal instantaneous 
unit bolus injection. R (t) is unitless and equals one when t equals zero. 
 
3) Arterial input function (AIF), Cartery (t): the concentration of contrast in the blood 
feeding areas (usually arteries) to the voxel of interest at time t. 
The residue function R (t) represents an intermediate quantity and is defined as 
       {
  ∫        
 
 
         
          
 (17) 
 
The residue function R (t) only relies on the hemodynamic properties of the voxel 
of interest. It demonstrates an abrupt rise due to the instantaneous injection of the 
contrast, followed by a plateau of duration that yields to the minimum transit time 
through the voxel of interest. The contrast agent will leave the each voxel of interest 
gradually over time, rather than instantaneously, due to the various transit times within 
the capillary bed. As a result, the residue function R (t) decreases gradually from one to 
zero. Figure 7 represents the examples of a transport function h (t) and the 
corresponding residue function R (t). The function h (t) is usually modeled by a gamma 
variate model (36). 
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Figure 7. Examples of the transport function h (t) with the mean transit time 
included and the corresponding residue function R (t). 
 
 
The tissue DECs, in fact, present the combination of the AIF and the inherent 
tissue properties (31). Thus, the impulse effect caused by the instantaneous contrast 
injection into the AIF needs to be removed via deconvolution, a mathematical method, to 
derive R (t). It turns out to be the formulation of the indicator-dilution theory (35). 
            
 
  
     [                ] 
    
 
  
     ∫  
 
 
                    (18) 
Where "*" is the convolution operator, ρ is the tissue attenuation, CH is the correction 
factor for the microvasculature hematocrit. Ctissue and Cartery are the concentrations of the 
contrast inside the tissue and the blood feeding areas, respectively and can be measured 
directly from the DECs.  
 
For the interpretation of this equation, in an ideal situation, the concentration of 
the contrast in the blood feeding areas, Cartery, is a superposition of consecutive contrast 
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injection Cartery (τ) dτ at time τ, and the concentration of the contrast that still remains in 
the voxel of interest at time t will be proportional to Cartery (τ) R (t - τ) dτ. Therefore, the 
total concentration of the contrast inside the voxel of interest is the integral of all the 
contributions over time (1). In order to compute TBF, the term TBF·R (t) should be 
isolated via deconvolution. At the time t = 0, R (0) = 1, and TBF is obtained.  
 
TBV can be obtained by equation (15). As for the calculation of MTT, apart from 
equation (1), another method can be used. By the definition of the transport function h (t), 
MTT is the ratio of the first moment of the transport function to its zeroth moment (1). 
      
∫         
∫      
 (19) 
 
1.5.2.3 Trapped-Tracer Model 
In the model of completely (approximately 100% first pass) trapped radiotracers, 
the blood flow can be calculated according to the fact that after the radiotracers are 
injected into cardiac output directly (the left ventricle or atrium), they are distributed to 
the individual organ/tissue in proportional to the blood flow to that organ. Therefore, the 
blood flow can be determined through the radioactivity distribution in the tissue (37).  
                                  (20) 
Where F is blood flow, C.O. is the cardiac output, A0 is the radioactivity of the tracers 
accumulated in the tissue, and At is the radioactivity of the tracer injected as total.  
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Tissue perfusion is determined by blood flow per gram of the tissue, which is 
then given by the equation (21). 
                                            (21) 
Where A0 / m0 presents the radioactivity concentration of the tracer in the measured 
tissue.  
 
However, cardiac output is difficult to measure at exactly the same time as the 
sample, so "reference sample technique" is usually used to replace the direct cardiac 
output measurement. In the microsphere study, when the microspheres flow to the organ, 
the arterial blood is withdrawn simultaneously at a rate of S (mL/min). The total activity 
of the withdrawn blood sample is labeled as As. The perfusion of the organ becomes to 
the equation 22. 
                      (22) 
 
1.5.3 Arterial Input Function Determination 
The quantitative analysis of the parametric perfusion maps relies on accurate 
determination of AIF, which describes the concentration of the tracer in the blood pool 
within blood feeding areas to the voxels of interest at a certain time. In simpler words, 
AIF is the dynamic evaluation curve of blood feeding (mostly arterial) areas. Currently, 
most researchers select AIF areas manually, by visual inspection of the anatomy in the 
regions containing the blood pool. The manual selection process requires specially 
trained operations, and the results vary with observers. Moreover, the complicated 
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structures in some tissues—such as brain—make the detection of the AIF areas difficult 
due to the scattered distribution of arteries. In addition, the selection of the global AIF in 
3D is even more complex because researchers have to select in each single slice and 
combine them together, which easily loses consistency in the entire 3D volume and 
causes large time and labor expenses. The automated process of finding the AIF, on the 
other hand, can reduce time and labor consumption, and more importantly, remove the 
inherent inter-operator variability and inconsistency in parallel experiments, or when 
comparing changes in follow-up studies during treatment therapy.  
 
There are several algorithms already developed that can automatically extract an 
AIF in perfusion studies (38-40). Briefly described, an AIF is selected by looking at 
various characteristics of an image voxels' time-intensity curves, such as peak height, 
peak width, wash-out time and wash-in process (41-43), and followed with cluster 
analysis, group independent component analysis and curve fitting analysis. In these 
studies, pre-knowledge of estimated AIF location is needed, and the technologies are 
based on spatial difference between AIF areas and tissues. Therefore, most of the studies 
are specific to certain tissues analysis, and they are only particularly used in a single 
imaging modality. In addition, so far, most of studies focus on MRI perfusion studies, 
and very few studies work on the automated determination of an AIF from CT and PET 
perfusion studies. Accordingly, it would be advantageous to develop a method for the 
automatic selection of an AIF widely used for any imaging modalities and broadly 
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applied in any tissue studies. To achieve this goal, more physiological conditions of 
organs should be involved to compromise the modalities differences.  
 
1.6 Research Objectives and Thesis Outline 
1.6.1 Research Objectives 
In this study, we develop an algorithm to pick an AIF automatically by 
classifying the characteristic parameters of each image pixel' dynamic evaluation curve 
between blood feeding areas and tissues. The selected AIF is used in producing 
parametric perfusion maps displayed for assisting diagnosis of physiological changes of 
a patient. It has six innovation points. 
 
First, this approach takes more physiological conditions into consideration and 
combines the modalities physics into the results. It is self-adjusted and tissue-
independent. Therefore, it is able to be used for any imaging modalities among CT, PET 
and MRI and applied in any tissues with minimal adjustment due to the different 
functionalities of varied organs.  
 
Second, the AIF determination by the manual selection is normally executed in 
one slice, while our automated method selects an AIF from the entire 3-D volume at one 
time, which increases the efficiency and consistency.  
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Third, this automatic generation requires interaction with physicians for 
physiological phase determination. And this requirement for the phase determination 
will not vary with operators. Therefore, the automated process is able to maintain inter-
operator consistency.  
 
Fourth, this technology is based on pixel-wised characteristics analysis, and 
therefore despite the scattered distribution of the blood supply areas, the selection of AIF 
pixels is still efficient and effective.  
 
Fifth, this technology transfers a multi-dimensional problem into several 2-D 
plots for later analysis, reducing the overall complexity.  
 
Lastly, we will test the algorithm in both CT and PET to realize both semi-
quantitative analysis and quantitative analysis. The accurate relationship between PET 
data and microsphere data will be built, through which the accuracy of using PET 
perfusion is determined.  
 
1.6.2 Thesis Outline 
Chapter 2 describes the technical development of the algorithm, including the 
flow chart and how it is developed step by step. A dynamic evaluation curve for each 
pixel in each slice of imaging data is produced to extract characteristic parameters. The 
characteristic parameters can include time to peak, maximum slope, and maximum 
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enhancement. In some cases, the characteristic parameters being extracted can further 
include wash-out slope and time to wash-out. Based on the extracted parameters, pattern 
recognition and classification can be carried out.  
 
Chapter 3 is a case study—CT myocardial perfusion study—to investigate the 
effectiveness and efficiency of the algorithm. The background is introduced first, with 
the estimated AIF areas included. Following is the description of the experiment 
procedure. A quantitative analysis is carried out to assess the performance of our 
algorithm.   
 
Chapter 4 is case study—PET abdominal perfusion study. In this study, the 
slightly modified algorithm is applied. The backgrounds of PET studies and microsphere 
study, which is the current "Gold Standard" for perfusion studies, are introduced. 
Following is the description of the experiment procedures. Quantitative comparison 
between microsphere studies and PET imaging studies is performed for assessing the 
consistency and accuracy of the algorithm. Manual selection of AIF and automated 
selection that we develop are compared to evaluate the effectiveness of the algorithm. 
 
 34 
 
CHAPTER II  
TECHNICAL DEVELOPMENT 
 
2.1 Flow Chart 
A general process for presenting data obtained from a perfusion study involves 
taking data obtained from imaging a tracer injected into a patient and presenting the 
dynamic information as a parametric image associated with anatomy. As previously 
described, selecting the AIF areas is an important step in obtaining quantitative 
measurements of blood flow through a region of interest. 
 
Figure 8 shows a process flow for perfusion analysis in which an AIF selector 
can operate. Referring to figure 8, imaging data from an imaging modality such as MRI, 
CT, or PET can be input to an automated AIF selection module for selection of the AIF 
areas. Once the selection of the AIF is obtained, a parametric perfusion map can be 
generated and the map output for display. 
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Figure 8. Flow chart illustrates the process flow for perfusion analysis in which an 
AIF selector can operate. 
 
Inside the automated AIF selection module, imaging data is received and may 
undergo a pre-processing step. The imaging data contains information of position (slice 
number), time point (in a time series), and pixel coordinates (e.g. x and y positions). The 
pre-processing step may be any suitable filtering or processing of data received from an 
imaging modality, for example, de-noising smoothing techniques or curve-fitting 
techniques may be applied.  
 
A dynamic evaluation curve for each pixel in each slice is produced to extract the 
desired characteristic parameters to determine perfusion information about a subject. The 
characteristics parameters include the three parameters of time to peak, maximum slope, 
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and maximum enhancement. In the more detailed characteristic parameters selection, 
two more wash-out parameters should be included: wash-out slope and time to wash-out.  
 
Based on the extracted parameters, pattern recognition is performed to identify 
relationships between extracted characteristic parameters. The identified relationships 
are used to classify datapoints of the imaging data for automatic tissue segmentation and 
AIF area determination. The pattern recognition includes generating two-dimensional 
plots based on the extracted parameters. The 2-D plots includes a plot of maximum slope 
vs. time to peak (S vs. T); maximum enhancement vs. time to peak (E vs. T); and, 
optionally, wash-out slope vs. time to wash-out (W vs. T).  
 
Peak and valley determination is made with respect to the 2-D plots, including a 
peak validator, a valley estimator, and a peak and valley determiner. The data on 2-D 
plots can be processed by the peak validator to obtain potential peaks and the valley 
estimator to obtain potential valleys. The potential peaks and valleys are then used to 
determine the real peaks and valleys (as opposed to peaks and/or valleys associated with 
local minimum noise or other artifacts) in the peak and valley determiner. The resulting 
datapoints are used to select the pixels indicating AIF areas. 
 
Lastly, the selected AIF areas are used to generate parametric perfusion maps for 
display and analysis. 
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2.2 Characteristic Parameters Extraction and 3-D Map Generation 
2.2.1 Features Selection—Phantom Study 
To determine the characteristic parameters of the DEC for the AIF area, we 
developed a perfusion phantom to mimic blood wash-in (to the tissue) and wash-out 
processes, which are critical to derive DECs for the dynamic evaluation. In this step, 
only CT scan is performed due to its low cost and fast acquisition. There is not much 
difference in using various modalities, because as mentioned before, we are trying to 
look for the characteristic parameters existing among the dynamic evaluations of all the 
modalities. In the preliminary study, the phantom was used to build a simplest model to 
help understand the complicated process better. The use of the phantom eliminates the 
metabolism process that occurs in the live bodies, since metabolism should not be 
considered when studying about perfusion. In addition, the use of this phantom reduces 
the sacrifice of animals. 
 
The design of the phantom is briefly described (Figure 9): a catheter with a 
diameter of 5 mm was used to mimic an artery, and therefore the change of contrast 
inside the catheter reflected the blood flow inside arteries. A polyurethane open-cell 
sponge with around 30 ppi porosity was utilized to mimic the tissue. A power injector, 
infusing iodine as a contrast and followed by flushing out the tracer with saline, helped 
the wash-in and wash-out processes.   
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Figure 9. The phantom was scanning using CT. 
 
The CT-TAC for the AIF areas and the CT-TAC for the surrounding tissues in 
the phantom study are shown in figure 10A. In agreement with the hypothesis, the CT-
TAC for the AIF areas clearly presents the characteristics features—the highest 
maximum enhancement, shortest time to peak and sharpest maximum slope—compared 
to the CT-TAC in the surrounding parts. Compared to the real tissue perfusion, the 
contrast enhancement in the phantom study stays for a much longer time since there is 
no natural bloodstream to clear out the contrast quickly. In addition, there is no suitable 
wash-out process existing in the phantom study. However, even though this preliminary 
phantom study cannot represent the real tissue function, we particularly chose the early 
time points with less physiological process involved in both real tissues and the phantom 
to obtain the characteristic parameters to increase the accuracy.  In an ideal tissue 
perfusion condition, the CT-TACs will be displayed like in figure 10B, which illustrates 
parameters.  
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Figure 10.  CT-TACs of the AIF areas and that of the surrounding tissues. A: CT-
TACs in the phantom study. Blue: AIF; red: tissue. B: Examples of TACs in an 
ideal tissue perfusion study, with three parameters annotated. Blue: AIF; red: 
tissue. 
 
The above three parameters are the general characteristics for AIF, but in some 
cases, only these three characters are not enough to differentiate the AIF from tissues. At 
this point, we need to find more characteristics for AIF so as to make our technology 
more solid. For example, if the tracer is completely trapped by the tissues, then this 
relationship between AIF and the curve of tissues is shown in figure 11. There is no 
wash-out process existing in the tissue. In this case, the wash-out parameters, wash-out 
slope and wash-out time, can also be considered as characteristics of AIF.  
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Figure 11. CT-TACs in the case of non-diffusible tracers that are used, with two 
more characteristic parameters annotated: wash-out slope and time to wash-out. 
Blue: artery; red: tissue. 
 
 
2.2.2 Characteristic Parameters Extraction 
The 4-D imaging perfusion data, containing the information of position (slice 
number), time point (in time series), and pixels coordinates (x, y positions), were pre-
processed using smoothing techniques. The smoothing techniques can be averaging, 
curve fitting or interpolation. In this study, interpolation and averaging were used. The 
DEC for each pixel in each slice was produced to calculate the first three parameters: 
maximum enhancement, maximum slope and time to peak (Figure 12). 
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Figure 12. The process of three characteristic parameters—maximum enhancement, 
maximum slope and time to peak—extraction and calculation. 
 
As illustrated in figure 12, HUarrival is the value of the change in attenuation (e.g., 
Hounsfield Unit) at the point of arrival of the tracer (or “bolus”) and HUpeak is value of 
change in attenuation at point of the maximum enhancement.  
 
To address system noise that may exist in a CT system, the calculations using CT 
imaging perfusion data can include thresholds such as a peak-dependent threshold θ1 to 
minimize negative affects to the determination of the maximum slope of a CT-TAC.  
Thus, the maximum slope can be given as: 
 
       
     
, where (23) 
               (24) 
                  (25) 
                      (26) 
 42 
 
An optimal value of α can be determined by selecting a steady and characteristic 
upslope. HU1 and HU2 are values of changes in attenuation at the two points selected by 
threshold θ1, and T1 and T2 are the corresponding time slices.  
 
The time-to-peak is the time at which a change in attenuation reaches the second 
point selected by the threshold θ1 that is temporally closer to the maximum enhancement 
(e.g., at HUpeak).  
 
Since the integrate of these three characteristic parameters of time to peak, 
maximum slope and maximum enhancement represents an uniform change trend, which 
contains useful information, the absence of any of these means an random signal. 
Therefore, if a pixel’s time-attenuation curve does not show all of the three characteristic 
parameters, then the pixel can be ignored as being either too noisy for calculation or as 
being in background of image (and not containing useful information). 
 
For the case that needs one step further, with wash-out process included, the 
DEC for each pixel in each slice was also used to calculate wash-out slope and time to 
wash-out (Figure 13). 
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Figure 13. The process of two characteristic parameters—wash-out slope and time 
to wash-out—extraction and calculation. 
 
Referring to figure 13, the wash-out parameter can be calculated in a manner 
similar to the determination of maximum slope, but on the side corresponding to the 
tracer being cleared (e.g., the wash-out process).  The calculations can use the peak-
dependent threshold θ1 to minimize negative effects to the determination of the wash-out 
slope of the CT-TAC by using the peak-dependent threshold θ1 to select two points, the 
gradient of which is an estimation of the wash-out slope. In particular, the gradient (e.g., 
the wash-out slope) is given as: 
         
        
          
        (27) 
                (28) 
                  (29) 
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Ipeak is the intensity value (or the associated unit for the particular imaging modality) at 
the point of maximum enhancement, and WOclear is the value at the point where the 
tracer is cleared up (this value may represent where the tracer is completely cleared up).  
WO1 and WO2 are the values at the two points selected by threshold θ1 and Two1 and 
Two2 are the corresponding time slices (e.g., the time values in the acquisition time serial). 
Time to wash-out can be the time when the dynamic evaluation curve reaches WO2. 
 
2.3 Pattern Recognition: Multi-Dimension to 2-D Plots 
Including the wash-out process, five characteristics parameters should be 
analyzed, and it would be hard to perform five-dimensional analysis for the classification. 
To solve this problem, several 2-D relationships were generated in respect with the five 
parameters for analysis. In this case, we transferred the multi-dimensional problems to 
several 2-D plots, and this is one of the key concepts for the entire algorithm. Three 
curves were generated (Figure 14): Maximum slope vs. Time to peak (S vs. T) (Figure 
14A), Maximum enhancement vs. Time to peak (E vs. T) (Figure 14B), and optional, 
Wash-out slope vs. Time to wash-out (W vs. T) (Figure 14C).  
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Figure 14.  2-D plots presenting Maximum slope vs. Time to peak (S vs. T) (A), 
Maximum enhancement vs. Time to peak (E vs. T) (B), and optional, Wash-out 
slope vs. Time to wash-out (W vs. T) (C).  
 
The pixels that have the same time points were used to generate the curves. For 
example, the S vs. T curve was generated by extracting all the pixels that have the same 
time points—time to peak—and taking the average of the slopes of the dynamic 
evaluation curve of those selected pixels. The black lines or dot lines are the mean 
values for each time, red lines or dot lines are mean plus standard deviation and blue 
lines are mean minus standard deviation. Starting now, physiology analysis started to be 
involved, and the real image data taken from animals was used to the later analysis. The 
data from the first two curves (S vs. T and E vs. T) were generated from CT myocardial 
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perfusion study, and the ones from the third curve (W vs. T) were from PET abdominal 
perfusion study. Regardless of modality, the patterns are similar, because the physics of 
the kinetic transport is similar, only the measurement method changes.  
 
The three 2-D plots clearly present particular patterns: parabolas or peaks. Each 
parabolas or peaks represent a physiological phase. Since the S vs. T curve and E vs. T 
curve are not independent, they show a similar pattern. In fact, they have a linear 
relationship. Therefore, once the patterns of S vs. T curve are analyzed, those of E vs. T 
curve are indicated.  In this case, only S vs. T was chosen to perform the later analysis.  
 
In the S vs. T (also in the E vs. T) curve, there are two parabolas, gradually 
ascending and then descending. The formation of parabolas means some pixels during 
this time to peak period have very steep slopes (and very high enhancements). 
According to the analysis before, these areas are usually blood pool areas. When 
evaluating the physiological process in this experiment, the physiological phases vary 
case by case. In this trail study, myocardial CT perfusion imaging was performed to test 
blood flow in the myocardium. The tracers were injected through a vein, and therefore 
the first blood pool areas are the right ventricle and the associated venous system. The 
second blood pool areas contained in the second parabola are left ventricle and the 
associated arterial system. When considering the AIF, the blood feeding areas are inside 
the second parabola. The number of the parabolas, referred to physiological phases 
varies with tissues due to the variable physiological processes in different tissues. For 
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example, in the liver, there might be two peaks: arterial phase and venous phase. The 
number can also change based on the scan phases we are imaging. Therefore, the 
emergence of different numbers of phases relies on the tissues and imaging protocol. 
Because the variables are known before a perfusion study, the particular pattern can be 
known. In such case, by selecting the specific pattern can this automated proceed 
simultaneously, and the patterns are not varied with operators. 
 
It should be understood that before the first parabola, the scattered points 
represent bones and interference tissues (usually with fluid (not blood) inside). The sharp 
slopes and high enhancements are due to the high attenuation caused by bones and some 
tissue fluids. Before the tracer washes in, this noise weighs more. However, once the 
tracer washes in, the dynamic change of tracer dominates. 
 
In the W vs. T curve, there is one peak. The formation of peaks, instead of 
parabolas, is due to the much longer acquisition of PET imaging (due to rapid transition 
between peaks) than that of CT imaging. This peak contains the information of the areas 
that have wash-out process. Since in this experiment, a non-diffusible tracer was used, 
only blood pool areas have wash-out process. Therefore, the AIF areas are presented in 
this peak area. The same thing as in the S vs. T curve, number of the phases depends on 
the tissues and imaging protocol, and it can be known before a perfusion study. 
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In order to realize the automated determination of AIF areas, automatically 
recognizing the locations of physiological phases and the tracer arrival point for each 
physiological phase is the key. In other words, we need to recognize valleys and 
peaks/parabolas on the 2-D plot curve.  
 
Figures 15, 17, 19 and 21 show detailed process flow diagrams of an example 
method of selecting AIF areas. It includes the steps of initialization, peak validation, 
valley estimation, peak & valley determination and AIF determination. Since the 
operation processes are similar among the three curves (S vs. T, E vs. T and W vs. T), 
only S vs. T is selected for describing the operation process. 
 
Figure 15. Initialization step of the automated process. 
 
Referring to figure 15, an initialization process is performed to segment pixels 
indicating bones and interference tissues. To segment (i.e., remove) bones and 
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potentially interference tissues, a threshold θ2 can be set to provide an absolute number 
limit for the first derivative of the S vs. T curve based on the principle that bones and 
interference tissues show sharp slopes. To find the start point (the bolus arrival point of 
the first peak) (Figure 16A), a zero-crossing method can be used. For some imaging 
modalities, such as CT, the start point is located in the first valley. Therefore, bones and 
interference tissues can be automatically segmented by setting the time restriction before 
the start point (Figure 16B). Once the start point begins, the dynamic change of the 
tracer dominates and the later process can be performed.  
 
Figure 16. Initialization process. A. start point; B. datapoints indicating bones and 
interference tissues segmentation. Label: x-axes are times (s), and y-axes are slope 
value. 
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Then it comes to the peak validation process to find peak candidates (Figure 17).  
 
Figure 17. Peak validation step of the automated process 
 
From the start point, the potential peak selection uses the zero-crossing method 
by looking for downward zero-crossings in the first derivatives of the S vs. T curves. 
Once the points are selected in the S vs. T curve, peak validation can be carried out. As 
mentioned before, the E vs. T curve has linear relationship with the S vs. T curve, and 
they should keep a consistency for each physiological phase. By this way, random noise 
can be eliminated. Therefore, a determination is made as to whether the selected points 
indicative of potential peaks in the S vs. T curve are consistent with that in the E vs. T 
curve (Figure 18 A&B). If a point is not consistent between the S vs. T curve and the E 
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vs. T curve, then the point is removed from being indicated as a peak. If the point 
indicative of a potential peak in the S vs. T curve is considered consistent with that in the 
E vs. T curve, then a determination is made as to whether the first derivative of the curve 
at the point is more than a threshold (θ3). This threshold is provided to remove small 
peaks, which may be indicative of noise or other signals.  
 
In some cases, small recirculation peaks exist that vary with the amount of the 
tracer in the scanning. In order to remove very small recirculation peaks that can be 
neglected the values of the mean of maximum slopes and the values of the mean of 
maximum enhancements should be bigger than those at the start points, respectively. 
Accordingly, a determination can be made whether the mean values at the points are 
bigger than that of the start points. If the values are not bigger, then the point can be 
removed.  
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The results of peak validation provide data regarding the refined peaks (Figure 
18C). 
 
Figure 18. Peak validation process. A, B: an example S vs. T curve (A) and E vs. T 
curve (B), respectively. C: refined peaks/peak candidates indicated in the green 
points. Label: x-axes are times (s), and y-axes are slope values (A), enhancement 
values (B) and slope values (C), respectively.  
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The step of valley estimation (Figure 19) is to look for refined valleys which 
potentially are the tracer arrival point for each physiological phase.  
 
Figure 19. Valley estimation step of the automated process. 
 
The potential valleys are determined by the upward zero-crossing method. For 
each physiological phase (presenting as a parabola), there is one valley and one peak. A 
subgroup is assigned for each peak candidate/refined peak in the data regarding the 
refined peaks. A subgroup contains all the potential valleys having time to peaks 
between that of the peak (with which the subgroup is assigned) and that of the previous 
peak. For example, the peak candidate Peak 1 can have a phase 1 subgroup assigned that 
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contains a collection of points of potential valleys between the start point and the first 
peak (with the start point included). The peak candidate Peak 2 has a phase 2 subgroup 
assigned that contains a collection of points of potential valleys between the first peak 
and the second peak. This arrangement continues for all peak candidates through Peak N, 
which is assigned a phase N subgroup containing a collection of points of potential 
valleys between the previous peak (e.g., N-1) and its peak (Figure 20A). 
 
Valley estimation is then carried out with in each subgroup. Since the tracer 
arrival point for each phase is generally among the few lowest valleys in each subgroup, 
a peak-dependent threshold θ4 is used to obtain the valley range. A determination is then 
made to whether the slope values are within the range set by the threshold. The arrival 
time point for each peak candidate is the last valley within the valley range assigned to 
the phase. The threshold θ4 is used to remove small valleys that should be neglected. The 
threshold θ4 and valley range Rvalley can be given as:  
            (30) 
                    (31) 
Speak is the mean of the maximum slopes in the range containing the peak point, Slowest is 
the lowest mean of the maximum slopes among all the boxes in this subgroup, and β is a 
variable for setting the threshold. An optimal determination of the threshold θ4 is to 
ensure that the valley range will not cover the points in the upgrade part of the S vs. T 
curve, and at the same time, to remove the small and noisy valleys. 
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If the slope value is not within the range Rvalley, the point can be removed; 
however, if the slope value is within the range, a determination of the tracer arrival point 
can be made and the results of the valley estimations for each subgroup can provide the 
data regarding the refined valleys (Figure 20B). 
 
Figure 20. Valley estimation process. A. an example of Peak 3 subgroup assignment 
(red points: potential valleys; green points: peak candidates); B. refined valleys 
(purple points) and refined peaks (green points). Label: x-axes are times (s), and y-
axes are slope value. 
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Figure 21 illustrates peak & valley determination using. 
 
Figure 21. Peak & valley determination step of the automated process. 
 
The refined peaks and refined valleys obtained through the peak validator and 
valleys estimator are used to determine the phases having real peaks and valleys. Each 
phase subgroup has its associated peaks and valleys determined. The difference between 
the index of a refined peak and refined valley can be determined using the refined peaks 
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and refined valleys for the phase 2 subgroup. The "index" refers to the coordinates of the 
points on the plots. A peak width threshold is used to ensure that the peak and the valley 
are not nearby each other, since in the physiological term, any change will not be that 
rapid. In this case, a width threshold may be 2 time segments. A determination is then 
made whether the index difference is less than 2. If the peak width is less than this 
threshold, the point can be determined to be a real peak or a real valley (Figure 22). 
 
Figure 22. The result showing selected real valleys (purple points) and real peaks 
(green points). Label: x-axis is time (s), and y-axis is slope value. 
 
 
By using the automatically determined phases with detected peaks and valleys, 
and on the basis of the physiological condition of the tissue, the phases containing AIF 
can be selected (Figure 23). Since the general tissue perfusion is also present in the AIF 
phase, the AIF can be determined by performing calculations refining the blood pool. 
The maximum enhancement and the maximum slope of an AIF are generally higher than 
that of tissues, and these two variables depend on the amount of tracer and the injection 
rate. In the general situation, the pixels that are in the AIF areas are the ones with the 
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maximum enhancements bigger than the mean enhancement at the point of the peak in 
the AIF phase, with the condition that the maximum slopes are bigger than the mean 
slope at the same point. Accordingly, AIF selection is carried out by picking pixels 
having maximum enhancements and maximum slopes bigger than the average 
enhancement and average slope at the point of the peak. The results of AIF selection 
provide segmented tissues. In an optional term, when consider wash-out process, the AIF 
selection further includes calculating wash-out slope and selecting the sharpest wash-out 
slope, which is determined to be bigger than the average wash-out slope at the point of 
the peak on the W vs. T curve; and calculating time to wash-out and selecting the 
shortest time to wash-out. The additional computations can be optional, depending on 
the type of tracer and the size of blood feeding areas undergoing the perfusion studies. 
The optional computations are usually included when trappable tracers are being used 
for the perfusion studies.  
 
Figure 23. AIF determination step of the automated process. 
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For example, when blood feeding areas are large, such as the area of the left 
ventricle and arteries (as compared to myocardium – which also does not indicate a high 
uptake of tracer), the difference between blood pool areas and tissues with respect to 
maximum slope and maximum enhancement stands out.  
 
In contrast, when blood feeding areas are very small, especially when the uptake 
of the tracer in some tissues, such as kidney, is too large to provide a clearly 
distinguishable difference between arteries and such tissues, it can be difficult to 
determine the appropriate maximum slope and the maximum enhancement.  A non-
diffusible tracer may be biologically trapped by certain tissues. Thus, inside blood pool 
areas, a non-diffusible tracer behaves similarly to a diffusible tracer. However, for the 
certain tissues, the non-diffusible tracer can become completely trapped by the tissue. In 
such cases, the tracer cannot be washed out from the tissue. It should be noted that the 
maximum enhancements of tissues are not necessarily lower than those of arteries. 
 
Examples of such studies include cerebral perfusion analysis and abdominal 
perfusion analysis. For these cases, the wash-out process which is more distinguishable 
than the maximum slope and the maximum enhancement is extracted to execute the 
pattern recognition and determine the appropriate AIF areas. For the wash-out 
parameters extraction, the peak validation can be carried out in a similar manner as with 
the S vs. T and E vs. T curves.  For example, zero-crossings in the first derivative that 
exceed a threshold are searched.   
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An automated AIF selector is presented that is applicable to many imaging 
modalities and tissue types with slight variations according to the physics of an imaging 
modality and tracer properties. For example, PET imaging is different from CT imaging 
in that there is less interference from bones and fluid. In particular, unlike the CT 
imaging data affected by the bones and fluids resulting in large attenuation, the start 
point (the tracer arrival point of the first peak) in the PET imaging data does not appear 
like a valley, but simply is an initial position for the following peak. This point can be 
obtained by looking for the first derivative that exceeds a threshold. Peaks and valleys 
are easier to be picked by simply looking for downward (for peaks) and upward (for 
valleys) zero-crossings in the first derivative that exceed another threshold. Due to less 
noise involved, the automated determination of peaks and valleys in PET studies can be 
simplified to omit steps for the noise removal. 
 
The example of resulting AIF is shown in figure 24. It clearly demonstrates that 
AIF involves the tracer kinetics of baseline, wash-in, wash-out and steady state. A 
recirculation occurs due to the use of a slightly large amount of tracer injected.  
 
This automated AIF determination technique replaces the conventional spatial 
classification method with physiological and functional classification method. In other 
words, it not only utilizes mathematical thinking, such as classification, dimension 
reduction and pattern recognition, but also takes more physiological considerations and 
explanations involved. In such way, physicians are able to understand and use this 
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technique in their perspectives. In addition, it does not require pre-knowledge of 
expected location of AIF areas, as the spatial classification does. Furthermore, this 
technology is based on pixel-wised characteristics analysis, and therefore despite the 
scattered distribution of the blood supply areas, the selection of input function pixels is 
still efficient and effective. Also, this technology is very straightforward; the dimension 
reduction on the multidimensional problems into several 2-D plots questions simplifies 
the entire calculation and analysis procedures. Last but not least, the process of noise 
removal in the procedure of "Peak and valley determination using the 2-D plots" is very 
robust, because it was developed based on CT signals, in which more background noises 
exist compared to PET and MRI signals. In this way, this technique can be used in 
perfusion calculations from both CT and PET, and might be extended to MRI.  
 
Figure 24. An example of resulting AIF. X-axis is time (s), and y-axis is in the unit 
of HU (Hounsfield Unit). 
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CHAPTER III  
CASE STUDY—MYOCARDIAL CT PERFUSION 
 
3.1 Introduction 
3.1.1 Coronary Artery Disease  
Coronary artery disease (CAD) is a leading cause of death in the developed 
world and the most common cause of mortality in the United States. CAD is a type of 
disease in which blood supply to the myocardium—heart muscle—is reduced due to 
narrowing in coronary arteries. The clinical problems associated with CAD are chest 
pain and myocardial infarction (MI) that causes heart attacks. The reduction in coronary 
blood flow results in absence of nutrition and oxygen exchange, and the state of 
oxidative stress would affect cardiac functions, such as heart rate, systolic wall stress and 
contractility. Each year, it is estimated of around 1.2 million Americans suffer MI 
clinically, and a further 195,000 cases of silent MI occurs each year (44).  
 
In order to maximize the medical management in CAD, research has been 
directed to the early detection, risk stratification and identification of CAD. It is 
important in non-invasive assessment of MI using medical imaging techniques because 
the imaging modalities are able to simultaneously provide both anatomical and 
functional assessment of MI. MI is presented by decreased myocardial perfusion, which 
refers to capillary-level blood flow in the myocardium.   
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3.1.2 Medical Imaging Used for Myocardial Perfusion Studies 
In the past decades, the functional imaging of myocardial perfusion has been 
mainly dominated by nuclear imaging techniques—SPECT and PET—as the clinical 
gold standard. They show very high diagnostic accuracy with a specificity ranging from 
87% - 94% and a sensitivity ranging from 85% - 90% (11). However, the costs 
associated to the two modalities are moderately high, and the two techniques still fall 
short of enabling quantification of transmural differences in the myocardial perfusion. 
Semi-quantitative measurement of myocardial perfusion using the MRI technique has 
been widely studied in research settings, with the sensitivity of 89% and the specificity 
of 87% (11). It does not require exposure to ionizing radiation and has greater flexibility 
of anatomical coverage. However, no metals should be involved in MRI imaging, since 
metal-based materials can interfere with magnetic fields. Additionally, MRI imaging 
requires a longer acquisition time. CT perfusion is capable of simultaneously providing 
both anatomical and functional assessment of myocardial infarction and its advantages 
of rapid acquisition time, nearly unaffected by heartbeat rate and the linear relationship 
between the attenuation and the concentration of the contrast will facilitate the 
quantitative measurement of hemodynamic parameters.  
 
3.1.3 AIF Addressed for Myocardial Perfusion Analysis 
To assess myocardial perfusion, the region of interest (ROI) that is selected as 
AIF for perfusion calculation is set either on the aorta (30) or on the left ventricle (45). 
However, AIF should be positioned in all the areas that feed blood into the tissues of 
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interest rather than only the aorta or left ventricle. Figures 25 (A, B) shows the 3-D 
heart external structure and blood supply areas.  
 
Figure 25. Heart structure (A) and cardiac blood pool and the myocardial blood 
supply (B). In the figure of B, the red arrows present the blood pool for supplying 
the myocardium; the blue arrows represent sequential blood flow: pulmonary vein 
→ left atrium → left ventricle → aorta → coronary arteries. 
 
Generally, the circulatory system in the body can be divided into either 
pulmonary circulation or systemic circulation. Deoxygenated blood returns from the 
body through the systemic venous system into the two major veins, the cranial and the 
caudal vena cava, which terminates in the right atrium. From the right atrium the 
deoxygenated blood is pumped to the right ventricle and subsequently into the main 
pulmonary artery. The main pulmonary artery quickly bifurcates into the right and left 
pulmonary arteries, which supply their respective lungs. Blood subsequently passes 
through the pulmonary capillaries where gas exchange occurs and continues into the 
pulmonary veins, left atrium, left ventricle and aorta. The coronary arteries supply the 
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myocardium and originate at the proximal part of the aorta. The major arteries of the 
coronary circulation are the left coronary artery, which divides into left anterior 
descending and circumflex branches, and the right coronary artery. Both of them 
originate at the base of the aorta, and lie on the surface of the heart, referred to as the 
epicardial coronary vessels. These arteries distribute blood flow to different regions of 
the myocardium and are classified as heart end circulation because they are the only 
blood supply source for the myocardium. Coronary artery disease is always caused by 
the blocked coronary arteries, and the damage of any of these three arteries will lead to 
critical outcomes.  
 
Based on the above described system, the pulmonary veins, left atrium, left 
ventricle, aorta and the arterioles (the last small branch of the arterial system from where 
the blood is released into the capillaries) are considered AIF areas. The direct blood 
supplies for the myocardium are coronary arteries, however, only coronary arteries to be 
the AIF can cause significant underestimation of the arterial TAC due to partial volume 
averaging (46). The current technologies will only pick the left ventricle or aorta, 
because they need pre-knowledge of where the AIF areas are located.  
 
3.2 Materials and Methods 
3.2.1 Animal Preparation 
In this example, a pig weighing 50 kg was used as a model of myocardial 
ischemia and reperfusion in this study after approval from Institutional Animal Use and 
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Use Committee (IACUC). Myocardial infarction was induced by using cardiac 
catheterization to occlude the blood flow of the left anterior descending (LAD) coronary 
artery for 90 minutes. CT scans were performed prior to and after the intervention. 
 
3.2.2 Tracer Validation 
The key for the quantitative analysis is how to transfer the value from the 
modality—CT number to the concentration of the tracer. In this study, iodine 
(Omnipaque 350) was used as the tracer for dynamic evaluation of perfusion. As 
aforementioned, the CT perfusion technique is based on the linear relationship that the 
change in attenuation is directly proportional to the concentration of the tracer material 
(30). To validate the relationship between the concentrations of iodine with CT number, 
a phantom study was performed. Five centrifuge tubes were filled with 15 ml sheep 
blood sample (heparin was used to prevent blood clotting) containing iodine with the 
concentrations of 0%, 1%, 5%, 10% and 15%. The contained iodine in each tube was 
mixed well with blood using glass rod. It should be noted that the mixing process should 
not cause bubbles inside, since bubbles have an influence on the later imaging. The five 
centrifuge tubes were arranged in parallel and placed on the bed of CT scanner. The CT 
scan was performed using 80 KV of voltage and 120 mAs of current. 
 
3.2.3 CT Scan Imaging Protocol 
The CT scan was performed with a 128-slice CT multi-row detector CT (MDCT) 
scanner (Biograph mCT, Siemens, Knoxville, USA) with a gantry rotation time of 300 
 67 
 
ms. The tracer of iodine (Omnipaque 350) was infused through the vein at a rate of 4 
ml/s. In the before-infarcted study, the amount of tracer used was 12 ml, and the after-
infarcted study, the amount was 24 ml. The difference in tracer amount is used to test the 
tracer-dependency of the automatic AIF selection algorithm. For both of the studies, a 
saline chaser of 64 ml at the same injection rate as that of tracer was utilized for wash-
out process. The scan was started 2 s after the initiation of the tracer injection and 
continued for 70 s such that the tracer can move through the entire heart. It was located 
through the entire heart. Twenty four slices of images were obtained with 3 mm slice 
thickness. The image protocol was performed at 80 KV due to the photoelectric effect 
for 80 KV photons, which are closer to the "k-edge" of iodine (31). Based on this 
kilovolt, the constant milliampere-second was set to be 120 mAs. Values for effective 
radiation dose were calculated by multiplying the dose-length product with a conversion 
factor (k = 0.014 mSv/mGy×cm). 
 
After imaging, a cardiac phase of 52% was selected for both before-infarcted and 
after-infarcted studies to achieve the least motion and artifacts, and also to contain both 
left ventricle and right ventricle.  A medium-smooth convolution kernel (B30f) was 
chosen to ideally reflect the iodine content in the myocardium. The axial images 
obtained by cine mode scan were reconstructed into 3600 images and a beam-hardening 
correction was applied in the reconstruction kernel to prevent beam-hardening artifacts 
that mimic the appearance of myocardial perfusion defects.   
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3.2.4 Algorithm Implementation 
In this case, the blood feeding areas are large, the difference between blood pool 
areas and tissues with respect to maximum slope and maximum enhancement easily 
stands out. Three characteristic parameters—maximum slope, maximum enhancement 
and time to peak—are sufficient to differentiate the AIF areas from other tissues.  
 
In the "characteristic parameters extraction and pattern recognition" step, we set 
α yield to 0.3 to give us a steady and characteristic upslope. In the "automated 
determination of AIF and segmentation of tissues" step, based on the principal of bones 
and interference tissues showing big attenuation, we set the threshold θ2 that was used to 
take off those tissues as 100. The slope derivative threshold θ3, which was used for 
removing small peaks, is set to be 3. To set threshold θ3, the variable β was determined 
as 0.1, so that the valley range was enough for taking off the small and noisy valleys 
without covering the points in the upgrade.  
 
Since different amounts of tracers were used before and after the infarction, the 
AIF determination strategy needs to be changed a little bit. "Maximum enhancement" is 
an absolute number change, and the larger amount of tracer would cause a much bigger 
enhancement showing in the E vs. T curve. However, "maximum slope" is a relative 
number change, and the larger amount of tracer will not affect the appearance of S vs. T 
curve too much. Accordingly, in the before-infarcted study, the pixels are picked with 
the maximum enhancements bigger than the mean enhancement at the point of the peak 
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in the arterial phase, whereas in the after-infarcted study, the pixels are picked with the 
maximum enhancements bigger than the mean plus standard variation of the 
enhancement at that point. For both studies, the AIF pixels selection are under the same 
condition that the maximum slopes are bigger than the mean slope at the point of the 
peak in the arterial phase.  
 
3.2.5 Perfusion Maps Generation 
Once AIF was selected, perfusion parametric maps were generated for each slice 
(each position). To obtain the perfusion maps, the maximum slope method was used. 
Again, myocardial blood flow (MBF) is computed as the ratio of the maximum slope of 
tissue TACs to the maximum arterial concentration. 
 
To make the perfusion parametric maps clearly show how blood flow distributes 
over the entire block of the tissue, we used OsiriX Imaging Software to reconstruct 3-D 
volume for perfusion maps. 
 
3.3 Results and Discussion 
3.3.1 Characteristic Parameters Extraction and Pattern Recognition 
Through the characteristic parameter calculation algorithm, the three parameters 
were extracted: maximum enhancement, maximum slope and time to peak. After the 3-D 
parameter maps were converted into two 2-D plots (S vs. T curve and E vs. T curve), the 
patterns for both curves were presented clearly (Figure 26 (A, B, C and D)).  
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Figure 26. The 2-D plots—S vs. T curves (A, C) and E vs. T curves (B, D) for both 
before-infarcted study (A, B) and after-infarcted study (C, D). 
 
On both S vs. T and E vs. T curves, the very sharp peaks or valleys that occur 
before the tracer arrives are caused by bones and interference tissues with fluid (not 
blood) inside. After the tracer arrival, since the tracer was infused from the vein, the first 
peak (or parabola) represents the contrast enhancement of the right ventricle and the 
associated venous phase. The second peak (parabola) demonstrates the contrast 
enhancement of the left ventricle/atrium, pulmonary veins, the aorta and its branches. 
The third peaks on both curves in the after-infarcted study are associated with the blood 
A B 
C D 
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recirculation to the right ventricle. However, in the before-infarcted study, the third 
peaks are not obvious because the amount of the tracer injected was half of that in the 
after-infarcted study. Therefore, the occurrence of the third peaks is tracer-dependent. 
AIF is not computed by recirculation, or the effect is too small to consider.  
 
3.3.2 Automated Determination of AIF and Segmentation of Tissues 
The automated processes for selecting peaks and valleys for both studies are 
shown in figure 27. Refined by the threshold requirements and the consistency features, 
two phases (right ventricle phase and left ventricle phase) or three phases (recirculation 
phase added) are automatically determined. No matter how many phases there are, the 
second phase mainly shows the blood pool in the left ventricle and associated major 
arteries, which are candidates for AIF. Throughout the process, the AIF is accurately and 
automatically selected. Using the similar method in the first phase, right ventricle and 
the associated major arteries are automatically segmented. 
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Figure 27. Automated process for the myocardial perfusion study. A and B show 
the automated selection of potential peaks and valleys, and real peaks and valleys 
for the before-infarcted study; C and D present that for the after-infarcted study. 
Label: x-axes are times (s), and y-axes are maximum slope values. 
 
The results of the automated AIF selection are shown as binary images in figure 
28 (C, D). In both studies, the AIF pixels are located in the blood pool in pulmonary 
vein, left atrium, left ventricle, aorta, and the branches of aorta and pulmonary vein, 
which are blood supply areas to coronary arteries to feed the myocardium. Even the 
blood supply areas blocked by some parts of myocardium can be selected accurately. 
Despite the scattered distribution of the blood supply areas, the selection of AIF pixels is 
more efficient and more accurate than the manually selected ones. The average TACs of 
all selected AIF pixels (Figure 28 (E, F)) are smooth, which represents the uniform 
patterns of the bolus wash-in and wash-out processes in both studies. 
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Figure 28. The resulted AIFs binary images (C, D) by the automated determination 
and the associated TACs (E, F) (x-axis: time (s); y-axis, HU) of AIFs, corresponding 
to the original anatomical images (A, B). A, C, E are in the before-infarcted study, 
and B, D, F are in the after-infarcted study. In the figures, blue circle: aorta; red 
circle: pulmonary vein; yellow circle: pulmonary artery; orange circle: postcaval 
vein; red arrow: small branches of pulmonary vein; green arrow: pulmonary 
arteriole branches; yellow arrow: sternal artery (originate from aorta). 
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The AIFs in both before and after infarcted studies are only presented within the 
first 16 seconds, because only wash-in process was taken into consideration in this case 
and the shortened time duration could display the changes much clearly. Both AIFs hit 
350 HU at the same time and the maximum enhancement of the after-infarcted study is 
higher. It matches the tracer administration: the total amounts of tracer are different, but 
the infusion rate is the same. 
 
3.3.3 Perfusion Maps and Quantitative Analysis 
The perfusion maps were generated, as shown in Figure 29 (A, B), to show the 
myocardial blood flow and distribution. By visually comparing the before (Figure 29A) 
and after (Figure 29B), it can be seen that there is normal enhancement in the 
inferoseptal wall, and dramatically reduced perfusion in the anterolateral wall, which is 
also much thinner. The 3-D perfusion volume (Figure 29 (C, D)) is reconstructed from 
series of perfusion 2-D maps to anatomically and functionally assess myocardial 
physiological conditions. 
  
The quantitative analysis was performed by drawing a region of interest (ROI) 
along the anterolateral wall as infarcted areas and a ROI along the inferoseptal wall as 
non-infarcted areas in both before-infarcted and after-infarcted studies, and taking the 
average perfusion values for comparison. The two corresponding ROIs are in the same 
size. In the before-infarcted study, the ratio of the perfusion values of infarcted and non-
infarcted areas is 1: 1. While in the after-infarcted study, the ratio is 1: 1.45 (Table I and 
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Table II). It indicates that the blood flow on the anterolateral wall was dramatically 
blocked in the after-infarcted study. It matches the experiment design, because the left 
anterior descending (LAD) coronary artery that was occluded is along the anterolateral 
wall. By comparing the ratios change, the quantitative analysis can be realized. We 
could not use the absolute number change to perform the quantitative analysis, because 
the absolute number change in perfusion values will be affected by many factors, like 
physiological change of myocardial cause by catheterization. In this study, before and 
after infarction, the non-infarcted areas have different absolute perfusion values. The 
possible explanation is that after the LAD was occluded, less blood flowed through the 
anterolateral wall. In order to keep the heart function normal, the heart pumped much 
harder, so that more blood would be pumped to the aorta to supply for the myocardium. 
Therefore, the perfusion value in the non-infarcted areas is higher in the after-infarcted 
study than that in the before-infarcted study. The perfusion values of infarcted areas in 
before and after the infarcted studies are similar, which means that the heart is still hard 
working to remain the function of the anterolateral wall, but this continuously hard 
beating will lead to the later heart failure. 
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Figure 29. The perfusion maps (A, B), and the associated 3-D perfusion volumes (C, 
D). A, C are in the before-infarcted study, and B, D are in the after-infarcted study. 
 
Table I. Quantification in the before-infarcted study 
Areas Perfusion values 
(ml/100g/min) 
Infarcted areas 96 +/-20 
Non-infarcted areas 97 +/-20 
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Table II. Quantification in the after-infarcted study 
Areas Perfusion values 
(ml/100g/min) 
Infarcted areas 91 +/-20 
Non-infarcted areas 132 +/-20 
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CHAPTER IV  
CASE STUDY—PET ABDOMINAL PERFUSION 
 
4.1 Introduction 
4.1.1 PET Imaging in Gastrointestinal (GI) Perfusion 
Positron emission tomography (PET) is one of the ideal methods to quantify the 
tissue perfusion because of its noninvasive property and the ability to accurately describe 
the distribution of radionuclides within the body, with absolute PET number reflecting 
the tracer concentrations. PET perfusion studies can be applied in many organs, 
especially in myocardium, and it becomes one of the "Gold Standard" methods to assess 
the cardiac perfusion studies. However, so far, no one employs PET scan in abdominal 
perfusion studies. Abdominal perfusion studies require more sensitive and accurate 
measurements because of the much more complicated structure in the abdomen than the 
cardiac structure. We believe that different cardiac outputs will result in different 
distribution and perfusion inside the abdomen, with kidneys, upper gastrointestinal (GI) 
and lower GI included. In this study, we plan to test our idea.  
 
4.1.2 
62
Cu-PTSM as PET Tracer 
PET perfusion can be measured accurately with tracers such as oxygen-15-
labeled water (H2
15
O) and 13N-ammonia (47), however, they can only be produced by 
cyclotron, to which most  PET center have no direct access. Generator-produced tracers, 
such as 
82
Rb-chloride and 
62
Cu, are widely used for the estimation of blood flow. 
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Although 
82
Rb-chloride has been successfully and extensively used in the detection of 
coronary artery disease (48), the short half-life of it, which is 1.3 min, prevents it from 
being an ideal tracer for PET perfusion studies. Furthermore, 
82
Rb-chloride is easily 
influenced by the metabolic activities of organs, making the quantification more difficult. 
 
62
Cu-labeled pyruvaldehyde bis (N-4-methylthiosemicarbazone) copper (II) 
(PTSM) is a lipophilic perfusion tracer. The 
62
Cu isotope has 100% positron decay and a 
physical half-life of 9.7 min, which is ideal of the PET instrumentation (49). 
62
Cu-PTSM 
is highly extracted and retained in cells and organs. The mechanism of 
62
Cu-PTSM 
entrapment in cells is involved with diffusion of it across the cell membrane with 
subsequent reduction of copper (II) to copper (I) by ubiquitous intracellular sulfhydryl 
groups. The reductive decomposition is able to bind nonspecifically to intracellular 
macromolecules, and hence, becomes trapped (47, 50). All the advantages make this 
compound promising for clinical use in quantitative measurement of tissue blood flow.  
 
The most significant difference from the properties of iodine-based tracers in CT 
scans and PET based 
62
Cu-PTSM is that this compound is completely trapped 
biologically by tissues. Therefore, except for the blood feeding areas—aorta and artery 
branches in the abdomen, there is no wash-out process existing in the tissues.  
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4.1.3 Dynamic PET Imaging Reconstruction 
The quantitative analysis for PET abdominal perfusion studies is sensitive to the 
imaging reconstruction process. Dynamic PET imaging is acquired as a collection of a 
series of time frames over adjacent time intervals. The data of each frame is 
reconstructed independently and used to form a set of images (51). The selection of 
adjacent time intervals gives a set of acquisition times. The longer acquisition time 
means longer scans with good counting statistics. However, it compromises the temporal 
resolution, leading to the loss of some important information. The shorter acquisition 
time, on the contrary, preserves the temporal resolution, but bring in too much noise due 
to insufficient counting statistics. In this case, some important information is obscured 
by noise. Moreover, shorter acquisition time results in more data within a certain time, 
which increases burden of data processing and requires more memory. In perfusion 
studies, the extraction of AIF requires data precise enough to form PET-TACs that are 
used to differentiate arterial blood and tissues. The quantitative measurement involves 
accurate AIF and stable data for the steady-state of tissues. An optimal reconstruction 
method should provide detailed information during the perfusion process and sufficient 
counting statistics at the steady period.  
 
In this study, we test our algorithm in a different image modality (PET) on a 
distinct tissue (abdomen) using dissimilar tracers (
62
Cu-PTSM) with completely different 
properties. Also, in order to find the optimal reconstruction protocol for PET abdominal 
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perfusion measurement, we iteratively refined the reconstruction protocols to optimize 
method. 
 
4.2 Materials and Methods 
4.2.1 Animal Preparation 
Three adult 60-80 kg ovine were used for the PET abdominal perfusion studies 
after approval from Institutional Animal Use and Use Committee (IACUC). Different 
cardiac outputs (blood flow output from left ventricles) were controlled using an 
implanted left ventricle assist device (LVAD). The animals were implanted with a 
centrifugal continuous flow LVAD in the left ventricular apex to the descending aortic 
position. The controlling modes are baseline (LVAD off, named mode 1), low 
continuous flow (LVAD flow 2.5 L/min, mode 2), high continuous flow (LVAD flow 4 
L/min, mode 3), low induced pulse flow (LVAD flow 2.5 L/min, mode 4) and high 
induced flow (LVAD flow 4 L/min, mode 5). The intestinal and renal blood flows were 
measured using microsphere and PET Scan techniques.  
 
4.2.2 Microsphere Measurement 
The microsphere studies were performed 20 minutes before each PET scan.  
Different colored microspheres were injected into the left ventricle during the five 
modes. Gold, samarium, ytterbium, europium and terbium color microsheperes were 
used in the five modes—baseline, low continuous flow, high continuous flow, low 
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induced pulse flow and high induced flow—respectively. The intestinal and renal tissue 
biopsies were harvested for the microsphere analysis after the study is terminated. 
 
4.2 3 
62
Cu-PTSM Preparation 
The Zn-62/Cu-62 generator, from Proportional Technologies (Houston, TX), was 
used to prepare 
62
Cu-PTSM. The generator was eluted 20 minutes earlier before the PET 
studies started, in order to maintain the radioactivity of the 
62
Cu-PTSM.  
 
In order to test the optimal radioactivity of the 
62
Cu-PTSM in the abdominal 
perfusion studies, two ovine studies (Study 1 and Study 3) were performed in the days 
when the generator arrived and one another studies (Study 2) were executed in the next 
days.  
 
4.2.4 PET Scan Imaging Protocol 
PET/CT scans were performed using Siemens Biograph mCT (Siemens 
Molecular Imaging, Tennessee, US). The scanner is equipped with 128 slice molecular 
CT and high resolution time-of-flight (TOF) PET with extended field-of-view (FOV). 
The subjects were positioned in head first-supine (HFS) orientated in the scanner. CT 
scans were implemented first through the whole body to optimize the region of interest, 
which locates from right kidney to small intestines, followed by PET scans. 
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In Study 1 and 2, the PET scans were performed over 8 minutes. 221 slices of 
images were obtained with 1 mm slice thickness. In the Study 3, the PET scans were 
performed over 10 minutes. Two hundred and twenty two slices of images were obtained 
with 1 mm slice thickness. The differences in the slice number and scan duration would 
have no influence on the final results. In three studies, the 
62
Cu-PTSM was infused into 
the left ventricle through a peripheral intravenous tube around 30 seconds later after the 
PET scans started. A 3-D Gaussian filter with a full-width-half-maximum response of 
5.0 mm was used as the kernel convolution for the later reconstruction. After each scan, 
the subjects were left inside the scanner for 40 minutes in order to let the radionuclides 
decay and be cleared out.  
 
4.2.5 PET Imaging Reconstruction 
In this experiment, we iteratively refined the reconstruction protocols to optimize 
method. First, through the entire study, the images were acquired at 30 sec/frame, in 
order to achieve a good counting statistics and also save memory space. Second, the 
images were acquired at 10 sec/frame. Even though this reconstruction method took 
more memory space, detailed information might be able to be obtained. These two 
methods were used for looking for physiological process information: the durations of 
baseline (delay for tracer injection), perfusion process and steady state. According to the 
results from these methods the perfusion process occurs from 30 sec (varies a little bit 
from study to study) to 3 min; and then the regions of interest enter into steady states. 
Accordingly, the third reconstruction (named adaptive reconstruction) method was 
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developed: during the first 3 min, images were acquired at 5 sec/frame, and in the rest of 
the process, the acquisition was obtained at 1 min/frame. The reason for the development 
of this reconstruction protocol is that we were trying to extract detailed information 
during the perfusion process, and remain a good counting statistics during the steady 
state. One step further, the fourth reconstruction method (named adaptive detail 
reconstruction) was developed for remaining more detailed information: during the first 
30 seconds, images were acquired at 10 sec/frame; from 30 seconds to 3 min, images 
were acquired at 3 sec/frame; and in the rest of the process, the acquisition was obtained 
at 1 min/frame. This reconstruction method could remain more detailed information 
during the perfusion process. However, to save some memory, the acquisition was 
obtained at 10 sec/frame during the first 30 seconds before tracer washed in. 
 
4.2.6 Algorithm Implementation 
In abdominal perfusion studies, blood feeding areas are very small, especially the 
uptake of the tracer in kidney is too large to provide a clearly distinguishable difference 
between arteries and kidneys. It is difficult to determine the appropriate maximum slope 
and the maximum enhancement. As mentioned before, the 
62
Cu-PTSM is completely 
trapped biologically by tissues when it is injected into the body. Therefore, unlike the 
behavior inside arteries or blood pool areas, the 
62
Cu-PTSM experiences no washout 
process in the tissues. To address this scenario, the additional computations involving 
wash-out process were included in the algorithm for automated AIF selection. 
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Since reconstruction determines the dynamic evaluation performance, the four 
types of reconstruction affect the strategy of algorithm implementation. According to the 
results from the reconstructions (see the "Results and Discussion" in "reconstruction"), 
the data from the reconstruction of 10 sec/frame is optimal to be used in automated AIF 
selection.  
 
In the "characteristic parameters extraction and pattern recognition" step, we set 
α yield to 0.3 to give us an optimal threshold θ1 for both wash-in parameters and wash-
out parameters calculation. The five parameters were extracted: maximum enhancement, 
maximum slope, time to peak, wash-out slope, and time to wash-out. Three 2-D plots 
were generated: S vs. T curve, E vs. T curve and W vs. T curve. In the "automated 
determination of AIF and segmentation of tissues" step, the slope derivative threshold, 
enhancement derivative threshold and washout derivative threshold were chosen based 
on the requirement that small noise should be removed completely. According to our 
imaging protocol, the tracers infused process happened within 4 min, and after that, the 
tracers were either cleared up by the arterial system or trapped by tissues. They kept 
steady state during the rest of the scanning period. Therefore, all the automated 
calculation was executed only in the time period from 0 min to 4 min.   
 
4.2.7 Perfusion Maps Generation 
Once AIF was selected, perfusion parametric maps were generated for each slice 
location. To obtain the perfusion maps, the trapped radiotracers model was applied.  
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Referring to the equation used in microsphere study, 
                                                                (32) 
 Where S is withdrawn rate, Atissue / mtissue presents the radioactivity concentration of the 
tracer in the measured tissue, and Aartery is the total activity of the withdrawn blood 
sample.  
 
This radiotracers trapped model can also be used in PET perfusion studies, but 
needs some modification. The typical PET data represents the tracer concentration, with 
the unit of Bq/mL—for example. In addition, in terms of withdrawn process, it depends 
on if the blood sample would be taken for the reference sample or cardiac output would 
be applied. In this study, neither blood sample was withdrawn nor cardiac output was 
captured (it is hard to calculate). A perfusion calculation method only using PET 
imaging was developed. Figure 30 illustrates the sampling example from PET perfusion 
for both AIF areas and tissues. Since AIF is the DEC of blood feeding areas, which 
describes dynamics of blood sampling. Since the unit of PET number is Bq/mL, the 
sampling rate s is 1 ml/(1min/sample interval).  
 
The tracer total activity in arterial sampling is the integral of radioactivity of all 
the sampling points (showing in the black dots in Figure 30) along the time period from 
tracer arrival to tracer clear-out. Due to the complexity and more techniques involved—
like curve fitting—in the integral operation, we could use sum to digitize the sampling to 
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replace integral operation. Then, the calculation process of the total activity of tracer in 
arterial sampling is  
         = ∫          
     
       
 
          = ∑        
     
           (33) 
Where dv = 1 ml, and Cartery is obtain from the PET number directly. Similarly, the 
calculation process of the activity of tracer in tissues is  
          = ∫          
       
       
 (34) 
 
Since tissue is acting like an integrator because it is taking tracer in and not 
giving it up. In such way, Atissue = Ctissue, when Ctissue is taken from a point at steady state 
(shown in figure 30). mtissue is calculated from the equation 
       (35) 
Since we are taking the unit volume sample, V equals 1 ml. The density of a tissue in 
general is approximately like water, which is 1 g/ml. In such way, mtissue yields to 1 g. 
Consequently, the perfusion calculation only by PET imaging can be achieved. 
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Figure 30.  Sampling example from PET perfusion for both AIF areas and tissues. 
Blue line: AIF; Black dots on the blue line: blood sampling; Red line: DEC of 
tissues; Black dots on the red line: tissue sampling. 
 
In this study, the sample rate is 6 ml/min, since we sampled at the rate of 10 
sec/min. During the wash-out process, because some free copper ions mix well with 
blood and stay with the blood or be trapped by lumen, the steady state of AIF is not 
going down to zero as expected. However, these copper ions will not flow into tissues 
with other blood. To avoid the overestimation of blood sampling, the data from AIF after 
the maximum enhancement was normalized based on the principle that the steady state 
should be at zero.  
 
4.2.8 DICOM File Generation and Workstation Use 
The calculated perfusion maps were written into Digital Imaging and 
Communications in Medicine (DICOM) files for importing into Syngo Workstation 
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(Siemens Medical Solution, Tennessee, USA) for the further analysis. DICOM is a 
standard in the radiology imaging for the exchange of images and the related information. 
A single DICOM file contains a header—storing the information about the patient's 
information, imaging protocol, study description, etc.—and all the image data (pixel 
data). When we process the data to generate perfusion maps, we deal with the image data. 
When it comes to importing data into the workstation, we need to deal with the header. 
There are four hierarchies for the header: 1. Patient; 2. Study; 3. Series; 4. Image. The 
image contains more detailed information—slice and frame.  
 
To write the perfusion maps into the specific DICOM files correctly, we need to 
make sure the patient and study remain the same as their originals. A new series should 
be created for each perfusion study. Since the perfusion maps are static, rather than 
being dynamically acquired, the series type should be changed from "dynamic" to 
"whole body". The related parameters, such as frame information, unique identification 
number and service-object pair, would also be changed. To display the perfusion maps 
with their original values, the "Rescale Slope" and "Rescale Interception" were set to be 
1 and 0, respectively. The image reconstruction factors were set accordingly.  
 
The perfusion maps in DICOM files were imported into the workstation, and 
fused with original CT whole body images, so that the positions of the hot spots 
displayed in the PET perfusion maps could be identified.  
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4.3 Results and Discussion 
4.3.1 Reconstruction  
Figure 31 (A, B) presents the reconstruction results of one of the studies with 30 
sec/frame reconstruction method and 10 sec/frame reconstruction method, respectively. 
Since the AIF area has higher concentrated tracer, it is supposed to have higher 
maximum enhancement and sharper maximum slope. However, in the result from 30 
sec/frame reconstruction, the maximum enhancement of the AIF area is much lower than 
that of kidneys. It is due to partial time effect; it is averaging over a long period of time 
so information in the high frequency is lost. Compared to the 30 sec/frame 
reconstruction, the result from the 10 sec/frame reconstruction is much better, which 
matches our expectation: the AIF area has the highest maximum enhancement, steepest 
maximum slope; kidneys have very high maximum enhancement due to the largely 
trapped tracers; the maximum enhancement and maximum slope of other tissues are not 
that high. In addition, the wash-out process only exists in the AIF area. However, the 10 
sec/frame reconstruction method is not perfect. Some detailed information is still 
missing if we were not sampling at a perfect time. In other words, partial time effect 
might still exist in this reconstruction method.  
 
The results from 30 sec/frame and 10 sec/frame reconstruction methods indicate 
that the tracer started to wash in at the time of 30th second, and the perfusion process 
started from the 30th second and ended up with 3rd min. The rest of the scanning 
duration is the steady state.  
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Figure 31. Reconstruction results of 30 sec/frame (A) and 10 sec/frame (B). A: 
green line: AIF; red and yellow lines: kidney; blue and purple lines: tissue. B: red 
line: AIF; blue and yellow lines: kidney; purple line: tissue. 
 
 
A 
B 
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Figure 32 (A, B) illustrates the results from the adaptive reconstruction method 
(5 sec/frame (0-3 min) + 1 min/frame (3-10 min)) and adaptive detail reconstruction 
method (10 sec/frame (0-0.5 min) + 3 sec/frame (0.5-3 min) + 1 min/frame (3-10 min)). 
The detailed information is preserved well in both results, but the adaptive detail one is 
better: the maximum enhancement of the kidneys is not supposed to be identical to that 
of the AIF area, but should be a little lower due to the mass of kidney tissues. However, 
adaptive reconstruction gives the result that the maximum enhancements of the kidney 
and the AIF area are almost the same. It might be because of the noise domination. Even 
though detailed information can be preserved in both reconstruction methods, the 
counting statistics is poorer than ideal. More noise domination means less useful 
information presentation. Detailed information of AIF is good for the later perfusion 
calculation, and therefore, the adaptive detail reconstruction could provide proper data 
for perfusion calculation.  
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Figure 32.  Reconstruction results of adaptive (A) and adaptive detail (B). A: light 
blue line: AIF; purple and blue lines: kidney. B: blue line: AIF; green and red lines: 
kidney; yellow line: tissue. 
 
 
A 
B 
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4.3.2 Characteristic Parameters Extraction and Pattern Recognition 
 According to the results from the last step, the 10 sec/frame reconstruction is 
better than the 30 sec/frame one. Additionally, the adaptive detail reconstruction is better 
than the adaptive one. In this step, 10 sec/frame and adaptive detail reconstruction 
methods were performed. Through the characteristic parameter calculation algorithm, we 
extracted five parameters: maximum enhancement, maximum slope, time to peak, 
washout slope and time to washout. Three 2-D plots were generated: S vs. T curve, E vs. 
T curve and W vs. T curve.  
 
Only S vs. T curves of both studies, as shown in Figure 33 (A, B), were picked 
for comparison. Compared to the S vs. T curve of the adaptive detail reconstruction 
study, the curve of the 10 sec/frame reconstruction study displays much clear patterns, 
and it is easy to differentiate the physiological phases. Accordingly, in terms of 
implementing the automated AIF selection algorithm, 10sec/frame reconstruction is 
better. However, if accurate quantitative analysis in perfusion studies is needed, more 
detailed information should be preserved. In such case, adaptive detail reconstruction is 
the optimal. According to the results, the 10 sec/frame reconstruction method is more 
suitable for automated AIF selection, since it makes the physiological phases on the 2-D 
plots easier to differentiate. The adaptive detail reconstruction method (10 sec/frame (0-
0.5 min) + 3 sec/frame (0.5-3min) + 1min/frame (3-10min)) is good for perfusion 
calculation. Even though the counting statistics of this reconstruction method is poor, 
detailed information is able to be preserved.  
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Figure 33. S vs. T curves of the data from 10 sec/frame reconstruction (A) and from 
adaptive detail reconstruction (B). Label: x-axes are times (s), and y-axes are 
maximum slope values. 
 
In this step, only data from 10 sec/frame reconstruction was performed. The 
patterns, as what we described before, are presented clearly (Figure 34). As shown in 
the Figure 34 (A, B), there are two peaks on both the S vs. T curve and E vs. T curve. 
The abdomen region was scanned from the right kidney (top) to the small intestines 
(bottom). Kidneys have very high metabolic activity. The tracer was wash into the AIF 
region first. Therefore, the first peak represents the arteries and the associated branches, 
and the second is a result of tracer in the kidneys. As shown in figure 34C, on the W vs. 
T curve, since only the arterial phase has the wash-out process, the single peak during 
the perfusion process is the expression of the AIF area in general. Another peak on the 
W vs. T curve is around the end of curve, which is around the time of 9 min. It is due to 
physical decay of copper-62.  Tissues do not have wash-out process. The system 
mistakes the physical decay to be wash-out. Since the decay behavior is very uniform, 
and our threshold is the maximum enhancement-dependent, the "times to wash-out" 
A B 
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should be close to each other. The shown peak means an accumulated time that "wash-
out" (actually decay) occurs. It should not be considered because it is out of perfusion 
process. 
 
   
 
Figure 34. The 2-D plots: S vs. T curve (A), E vs. T curve (B) and W vs. T curve (C). 
Label: x-axes are times (s), and y-axes are maximum slope values (A), enhancement 
values (B) and wash-out slope values (C), respectively. 
 
 
 
A B 
C 
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4.3.3 Automated Determination of AIF 
The automated processes for selecting characteristic points are shown in figures 
35-37. The arteries and kidneys phases were accurately selected. 
 
Figure 35. Automated process for S. vs. T curve. Label: x-axes are times (s), y-axes 
are maximum slope values. 
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Figure 36. Automated process for E vs. T curve. Label: x-axes are times (s), y-axes 
are enhancement values. 
 
 
Figure 37. Automated process for W vs. T curve. Label: x-axes are times (s), and y-
axes are wash-out slope values. 
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To pick the AIF, the results from the three plots were integrated. The selected 
pixels satisfied the following requirements: the maximum enhancement is bigger than 
the mean enhancement at the point of the peak (in the phase of interest) on the E vs. T 
curve, the maximum slope is bigger than the mean slope at the point of the peak on the S 
vs. T curve, and the wash-out slope bigger than the mean wash-out slope at the point of 
the peak on the W vs. T curve. These selected pixels further meet the time requirements 
where the time to peak associated with these pixels are within the peaks (in the phases of 
interest) on both E vs. T curve and S vs. T curve, and the time to wash-out is within the 
single peak on the W vs. T curve. 
 
The result of the automated detection of AIF pixels is shown in a 3-D binary 
image in figure 38. An intact and clear arterial system is shown in this figure: a main 
artery originated from aorta and then distributed into two branches, which are femoral 
arteries. This artery system is the blood feeding areas for the entire abdomen.  
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Figure 38. 3D AIF region—femoral system 
 
The average PET-TAC, as shown in figure 39A, of the AIF pixels is smooth and 
represents the uniform patterns of the tracers wash-in and wash-out processes. When 
applied the data from the adaptive detail reconstruction on the selected AIF areas, the 
transferred PET-TAC is shown in figure 39B. The maximum enhancement of the 
transferred PET-TAC is much higher than that of the original one, which means that 
more detailed information is preserved. In addition, more sampling provides higher 
accuracy. The modified PET-TAC, as shown in figure 39C, is the one with the 
normalized data to avoid the effect brought by free coppers staying inside lumen.  
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Figure 39.  PET-TACs of AIF areas. A is from the data from 10sec/frame; B is from 
the data from adaptive detail; C is the modified TAC based on B. Label: x-axes are 
time (s), and y-axes are radioactivities. 
 
4.3.4 Perfusion Maps and Fused Perfusion Maps with CT Anatomy Images 
Figure 40 (A, B) shows the generated perfusion maps of the kidneys and upper 
GI. Perfusion values of lower GI are too low to be detected. Figure 41 (C, D) shows the 
fused perfusion maps with CT anatomy images that are corresponded with original CT 
whole body images, as shown in figure 41 (A, B). The registration of the two modalities 
provides the information for both anatomy and functionality of the tissues.  
A B 
C 
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Figure 40. Perfusion maps showing kidneys (A) and upper GI (B). 
 
 
Figure 41. Fused perfusion maps showing kidneys (C) and upper GI (D) with CT 
anatomy, and the corresponding original CT whole images (A, B). 
A B 
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4.3.5 Quantitative Analysis for Microsphere and PET Imaging Studies 
To evaluate the consistency and effectiveness of this algorithm used in PET 
imaging, two methods of quantitative analysis were performed. Since very low 
radioactivity of tracers was applied in Study 2, the counting statistics were not sufficient 
to get an accurate measure, therefore, only perfusion data from Study 1 and Study 3 were 
used. 
 
The first method is to test if the microsphere data matches with PET data. Bars 
were used to present PET data range and an individual data to present microsphere data, 
because even in a single organ, the perfusion distribution is different through all the 
spots. However, only a small spot was harvested for microsphere measurement, but it is 
hard to tell the location of the spot where the biopsy was taken. On the contrary, PET 
imaging scanned the entire organ, and the perfusion values of all the spots in this organ 
could be collected. Therefore, we can conclude that if the microsphere data is located 
inside the range of the PET data, the PET data is accurate.  
 
The comparison of PET data and microsphere data is shown in figure 42 (A, B, 
C and D). The edges of the bars in PET data represent 75% (top) and 25% (bottom) 
percentiles of the perfusion values of an organ. The upper limit (shown as the highest 
line) is the maximum value of the perfusion, and the low limit (shown as the lowest line) 
is the minimum value of the perfusion. The red lines inside the bars are mean values. 
Some mean values are not in the middle of the bars because the perfusion distribution of 
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an organ does not match the normal distribution. Microsphere data is shown as an arrow 
with values denoted.   
 
In the Study 1, all the perfusion values measured from microsphere studies are 
filled inside the bars of the corresponding PET data. In the Study 3, most of the 
microsphere data matches well with PET data except for mode 3 and mode 4. The 
microsphere data is so extraordinary high that it is illogical. It would be highly abnormal 
if a tissue could perfuse at the rate of 15 ml/min/g.  It is likely that there were some 
problems with the catheters when performing blood sampling. This is a weakness of 
microsphere measurements. 
 
The results indicate that the algorithm of automated AIF selection in PET 
perfusion studies provides consistency in quantitative analysis. It is relatively accurate 
and not easily affected by the technique itself. On the contrary, even though microsphere 
measurement might offer the most accurate results if this technique is performed in a 
perfect way, the technique is somewhat inconsistent and ineffective. 
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Figure 42. The comparison of PET data and microsphere data in Study 1 and Study 
3, with modes of 1, 2, 3, 4 and 5. A: Study 1 kidney perfusion values; B: Study 1 
upper GI perfusion values; C: Study 3 kidney perfusion values; D: Study 3 upper 
GI perfusion values. PET data ranges are shown using bars, and microsphere data 
is shown using arrows. The red circles are suspect numbers. 
 
The second method is to detect the trend of perfusion changes when different 
control modes for cardiac outputs were applied. The first method roughly assesses the 
effectiveness of the algorithm and the PET imaging in perfusion studies. The second 
method is to detect the subtle changes in tissue perfusion brought by the blood flow 
controlling (mode 1, 2, 3, 4 and 5) using PET imaging. To evaluate this, the tissue 
perfusion trend detected from PET imaging is compared with that from microsphere data. 
Figure 43 (A, B) presents the comparison of microsphere data and PET data in averaged 
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perfusion values through all the studies of kidneys (Figure 43A) and upper GI (Figure 
43B), and Figure 43 (C, D) illustrates the comparison of microsphere data and PET data 
in perfusion values of kidneys (Figure 43C) and upper GI (Figure 43D) only in Study 3. 
The most suspiciously abnormal data, like the super high perfusion values in 
microsphere studies, was removed. The Study 3 was selected only as an example. 
 
Figure 43 (A, B) indicates that different cardiac outputs result in varied tissue 
perfusions. However, the change trends in the tissue perfusions corresponding to each 
blood flow controlling mode from PET data and microsphere data are not identical. 
According to the figure 43 (C, D), the change trend in tissue perfusions from PET data 
in Study 3 is similar to that from microsphere data, but still not exactly the same. It also 
demonstrates the change trends in tissue perfusions in different PET imaging studies are 
not identical. The blood distribution to an organ varies with cardiac outputs and also 
differs with animals. 
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Figure 43. The comparison of PET data and microsphere data in trend detection. A, 
B: the comparison of microsphere data and PET data in averaged perfusion values 
through all the studies of kidneys (A) and upper GI (B); C, D: the comparison of 
microsphere data and PET data in perfusion values of kidneys (C) and upper GI (D) 
only in Study 3. 
 
The methods to measure the standard deviations for microsphere studies and PET 
imaging studies were not exactly the same. Only two microsphere biopsies were 
harvested for each organ, and biopsy spots were far from each other. Each standard 
deviation of microsphere data for each organ was calculated from the data of the organs 
from all the animals. The microsphere results show that the standard deviation relative to 
the mean is high, so the confidence interval is not wide. Since a confidence interval is 
used to indicate the reliability of an estimate. A bad confidence interval indicates the 
confidence range cannot capture a true population parameter of the given samples. 
Therefore, it is not appropriate to say that the change trend shown in the microsphere 
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data is correct. The reason causing this problem is that even though microsphere 
measurement in perfusion studies is the "Gold Standard" study, it is subject to the 
technique itself. PET perfusion studies can provide perfusion values from both a single 
point and the overall value of an organ. The standard deviation for each organ was 
calculated by drawing a ROI with 20 pixels contained on each animal and averaging the 
standard deviations for all the animals. The PET imaging data gives shorter error bars, 
which means that the standard deviation relative to the mean is low. Accordingly, PET 
imaging can provide more consistent results.  
 
4.3.6 Comparison Studies between Automated Selection and Manual Selection of AIF 
Inveon Research Workplace (IRW, Siemens Healthcare, U.S.A.) was used to 
realize the manual selection of AIF. Femoral artery was selected by drawing a 3-D 
cylinder to cover the entire blood vessel. The resulting AIF is shown in figure 44A. 
Then we changed a slice and used the same method select femoral artery, but made the 
cylinder a little smaller. The cylinder was still inside the femoral artery. Another 
resulting AIF is shown in figure 44B. In fact, the two drawn cylinders are almost the 
same. However, the maximum enhancement of the first AIF is 4E4 Bq/ml, and that of 
the second AIF is 7.5E4 Bq/ml, which is twice of that of the first AIF. The resulting 
perfusion number calculated from the second AIF drawing might be twice of that from 
the first AIF drawing. The results indicate that slight change in selecting the AIF region 
might cause a big influence in the result. The slight change happens between operators 
with operators, and slice with slice even one person operates. On the contrary, the 
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automated AIF selection remains consistency in the entire study, because the automated 
AIF selection is able to give the AIF areas in three dimensions at one time, and the 
selection slice by slice is not necessary. In addition, the automated AIF selection reduces 
inter-operator variation, since the only input for the AIF selection is to choose the 
physiological phase that contains AIF region, and this phase is known, according to 
which study is performing (such as myocardial study and abdominal study), before the 
scan. 
 
Figure 44. Resulting AIFs with the first manual selection (A) and the second 
manual selection (B). 
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CHAPTER V 
CONCLUSION AND FUTURE WORK 
 
In this study, a technique for performing automated determination of arterial 
input function (AIF) areas was developed. Briefly described, imaging data acquired from 
imaging modalities is used for extracting characteristic parameters (maximum 
enhancement, maximum slope, time to peak, and optional, wash-out slope and time to 
wash-out). The extracted parameters were converted to a plurality of 2-D plots. The 2-D 
plots include a plot of maximum slope vs. time to peak (S vs. T); maximum 
enhancement vs. time to peak (E vs. T); and, optionally, wash-out slope vs. time to 
wash-out (W vs. T). Pattern recognition is performed to identify the physiological phases 
on 2-D plots. Through automatically finding peaks and valleys of each phase on the 
plurality of 2-D plots, the AIF areas and some other tissues can be determined.  
 
This technique/algorithm was tested in CT myocardial perfusion studies and PET 
abdominal perfusion studies. In the CT myocardial perfusion study, perfusion parametric 
maps were generated based on the automatically determined AIF areas, and quantitative 
analysis on infarcted and non-infarcted areas was performed. In the PET abdominal 
perfusion study, perfusion parametric maps were generated based on the automated AIF 
selection, the comparison between PET data and microsphere data was performed, and 
the comparison between automated selection and manual selection of AIF areas was also 
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implemented. From the results in this study, some conclusions are made for this 
technique. 
 
First, this automated AIF determination technique replaces the conventional 
spatial classification method with physiological and functional classification method. In 
other words, it not only utilizes mathematical thinking, such as classification, dimension 
reduction and pattern recognition, but also takes more physiological considerations and 
explanations involved. In such way, physicians are able to understand and use this 
technique in their perspectives. In addition, it does not require pre-knowledge of 
expected location of AIF areas, as the spatial classification does. 
 
Second, the technique is applicable to different modalities. It functions well in 
both CT and PET imaging in tissue perfusion studies. Since the dynamic evaluation 
curves are used as a basis for the technique and the curves from the imaging modalities 
of PET, CT and MRI behave similar, this technique can be extended to MRI, as well. 
 
 Third, this technique is effective on many tissues. Even though some slight 
changes are needed case by case in terms of tissue physiology, the central algorithm 
remains the same when implemented in both myocardial and abdominal perfusion 
studies. Accordingly, this technology can be used in varied tissue perfusion studies, 
minimally modified with physiological phase selection. 
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Fourth, the technique is efficient and effective. It is based on pixel-wised 
characteristic analysis, and therefore the resolution of generated perfusion maps would 
be good. The automated selection of AIF areas is performed through the entire 3-D 
volume at one time, instead of selecting the AIF areas in 2-D slices manually. In such 
case, it reduces time and labor consumption. The results from the generation of 
parametric perfusion maps indicate that this technique is effective.  
 
Fifth, this algorithm provides consistent results. The comparison between PET 
imaging data and microsphere data, and the comparison between automated selection 
and manual selection of AIF areas demonstrate that this automated AIF selection 
technique provides more consistent results than microsphere measurement and manual 
AIF selection.  
 
As for future work, the algorithm should be tested in MRI perfusion studies and 
even in ultrasound perfusion studies. As mentioned before, this algorithm might be 
effective in both imaging modalities, since they are also based on dynamic evaluation 
curves. The potential differences would be in the resolutions of parametric perfusion 
maps which are controlled by the imaging systems. The pre-processing techniques of the 
raw data acquired from the imaging might be different. For the long acquisition time, 
interpolation will be used; for the poor counting statistics, smoothing will be utilized; for 
large noise, curve fitting might be applied.  
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In addition, since this algorithm was developed using MATLAB, and this 
technique is based on pixel-wised operation, the calculation is slow. It would be much 
better if this algorithm can be transferred to C++ or Java to improve the function pace. 
 
Lastly, more animal studies and more tissue perfusion studies are needed for 
testing this technique. It also needs to be evaluated in liver perfusion studies because the 
liver system is different from other organs, and it has two blood input paths: the arterial 
path and the venous path. It would be beneficial if this algorithm could differentiate 
these two blood input areas, and provide accurate perfusion maps. 
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